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Amyotrophic Lateral Sclerosis (ALS) is a motor neuron disease characterizeby 
devastating symptoms, such as muscle weakness, paralysis, and death within 5 
years of disease onset. Mutations in human (VAMP)-associated protein B 
(hVAPB) gene cause ALS8. Interestingly, the Drosophila VAPB (DVAP) is 
required at the Drosophila larval neuromuscular junction (NMJ), to control 
bouton morphology. In Pennetta’s lab Drosophila Sac1, a phosphoinositide-4-
phosphate (PI4P) phosphatase, was identified during a genome-wide yeast two-
hybrid screen, as a DVAP binding partner. VAP plays a role in regulating PI4P 
turnover in yeast and phosphoinositides are implicated in some 
neurodegenerative processes. In this PhD thesis, Sac1-DVAP interaction is 
used as the starting point to identify the mechanism that is altered when DVAP 
function is impaired. Thus, the possibility that the cellular pathways regulated 
by PI4P are affected in VAPB-mediated neurodegeneration was explored. First, 
the Sac1-DVAP association was confirmed in vitro by coimmunoprecipitation. 
Subsequently, we found that these two proteins colocalize in vivo at the ER 
membranes. Then, immunohistochemical analysis of Drosophila larval NMJ 
revealed that Sac1 and DVAP are involved in similar pathways. They both have 
a function in microtubule stabilization in the presynaptic boutons and axonal 
vesicle transport at the presynaptic compartment. They also seem to contribute 
to the spectrin-actin cytoskeleton stabilization at the postsynaptic compartment 
of the NMJ. Lastly, we reported that reduced levels of Sac1 phosphatase cause 
progressive neurodegeneration. Moreover, Sac1 is trapped into cytosolic 
aggregates induced by the expression of the ALS8-mutant allele of DVAP, and 
it does not localize to its original place in the cell. All together these results 
suggest that in ALS8 hVAPB seems to have a dominant negative effect on 
Sac1. Sac1 mislocalization could inhibit the dephosphorylation of PI4P. This 
PhD work further confirms Sac1-DVAP interaction and it suggests a 
mechanism underlying ALS8 pathogenesis, supporting the idea that altered 
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Chapter 1: Introduction 
 
The main focus of this PhD thesis is to understand how mutations in the VAPB 
gene can lead to neurodegeneration in a subgroup of Amyotrophic Lateral 
Sclerosis (ALS), using Drosophila melanogaster as an experimental model. 
Firstly, this chapter will briefly introduce the reader to motor neuron diseases, 
and then, describe the main features of ALS. Secondly, the use of fruit flies in 
studying neurodegenerative diseases will be illustrated. The main 
characteristics of VAP proteins will be examined. Thirdly, the ALS subtype 
caused by mutations in the human VAPB gene will be examined. Lastly, some 
of the known interacting partners of VAP proteins, in particular those involved 
in lipid metabolism and homeostasis, will be discussed, in order to understand 
whether VAPB is involved in controlling a particular class of lipids with 
regulatory functions, such as the Phoshoinositide phosphates (PIPs).  
 
 1.1 Neurodegenerative diseases 
 
Neurodegenerative diseases are devastating disorders characterized mainly by 
progressive death of particular neuron subtypes. This group of disease includes, 
among others, Alzheimer’s disease (AD), Parkinson’s disease (PD), 
Huntington’s disease (HD) and ALS. Neurons of the cerebral cortex and of the 
hippocampus are degenerated in the AD [Zarow et al., 2005]. Loss of 
pigmented dopaminergic neurons in the pars compacta of the substantia nigra 
was observed in PD cases [Atasoy et al., 2004]. Degeneration of neurons in the 
cerebral cortex and in the striatum was reported to be associated to HD cases 
[Rosas et al., 2008]. Lastly, motor neurons are degenerated in ALS [Ferraiuolo 
et al., 2007]. The reason for this neuronal selectivity is still an ill-defined aspect 
of these diseases [Bonini and Fortini, 2003; Bruijn et al., 1998]. 
 
Much effort has been invested in research aimed at identifying the molecular 
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causes of these diseases and a number of intracellular mechanisms/processes 
are altered in neurodegenerative diseases [Bossy-Wetzel et al., 2004]. 
Mitochondrial dysfunction, increased oxidative stress, altered vesicle transport, 
altered endocytosis, autophagy, disruption of the proteosome system and the 
unfolded protein response, synaptic activity, and apoptosis are only some of the 
intracellular problems that have been reported in neurodegenerative diseases, so 
far [Bossy-Wetzel et al., 2004]. Nevertheless, the exact molecular mechanisms 
underlying the pathogenesis of these diseases are still poorly understood 
[Bossy-Wetzel et al., 2004].  
 
1.2 Amyotrophic Lateral Sclerosis  
 
ALS belongs to the group of motor neuron diseases (MNDs) that are 
neurodegenerative disorders in which motor neurons are selectively affected 
[Ferraiuolo et al., 2007]. This disease is the most common and best-
characterized MND, and is also known as Lou Gehrig’s disease after the 
baseball player who died because of this fatal disorder.  
 
A main feature of ALS is the progressive loss of both upper and lower motor 
neurons. Selective dysfunction and consequent death of these neuronal cells in 
the brain and spinal cord leads to denervation of skeletal muscles [Leigh and 
Garofolo, 1995]. As motor neurons directly (lower motor neurons) or indirectly 
(upper motor neurons) control muscle contraction, spasticity, hyper-reflexia, 
paralysis, general weakness, and atrophy of voluntary muscles occurs in ALS 
sufferers [Mulder, D.W., 1986; Talbot, K., 2002]. Respiratory failure due to 
denervation of the diaphragm and respiratory muscles usually culminates in 
death of the ALS patient [Mulder 1986; Talbot et al 2002]. Nevertheless, there 
is increasing evidence showing that in ALS, neurodegeneration does not affect 
only motor neurons, but also neurons in different areas of the brain, such as the 
anterior and prefrontal temporal lobe [Zago et al., 2011]. In fact, clinical 
symptoms characteristic of lesions in the anterior and prefrontal temporal lobe, 
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as the ones of Fronto-temporal Dementia (FTD) have also been observed in 
some cases of ALS [Zago et al., 2011].  
 
ALS is the most common motor neuron disease with an incidence of 5:100,000 
individuals. The cases of sporadic ALS (SALS) are more frequent (90%) 
compared to 10% of familial (FALS) l form cases [Kunst et al., 2004]. The 
mean age of onset is between 45-60 years and the average survival is 
approximately five years from the first onset of symptoms [Mulder, D.W., 
1986; Talbot, K., 2002]. Nevertheless, cases of juvenile ALS are characterized 
by age of onset of <25 years [Al-Saif et al., 2011].  
 
Such devastating manifestations of ALS are accompanied by the formation of 
cytosolic inclusions of mutant proteins in the cell body and axons of motor 
neurons [Ince et al., 1998; Piao et al., 2003]. These aggregates can be detected 
in post-mortem brains from ALS patients [Kato et al., 1997]. In addition, 
protein aggregation has also been demonstrated to be present in ALS animal 
models in association with fundamental features of the disease, such as 
locomotion defects [Watanabe et al., 2001; Chai et al., 2008; Wang et al., 
2009]. It is still unclear what role the protein inclusions play in the disease: 
whether they are a cause or consequence of neurodegeneration or, in addition, 
whether they have a protective effect on the motor neurons [Brown Jr., 1998; 
Couillard-Despres et al., 1998]. The protective role of these cytosolic 
aggregates may be the trapping of harmful proteins.  
 
ALS is genetically diverse, with at least 18 loci that have been found to be 
mutated in FALS cases (Table 1). The functional analysis of the proteins 
encoded by the ALS-causing genes and their interacting partners has helped in 
determining some of the cellular pathways that are altered in this MND 
[Ferraiuolo et al., 2007]. The genes that are altered in ALS patients encode 
proteins implicated in several molecular pathways including endosomal 
trafficking (Alsin in ALS2), oxidative stress (SOD1 in ALS1), protein 
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degradation pathways (Ubiquilin-2 in ALS15), and RNA processing (TDP-43 
in ALS10). These proteins are not always associated with loss-of-function 
mutations in ALS pathogenesis. In fact, there is evidence that ALS cases are 
associated with SOD1 gain-of-function mutations [Siddique et al., 1997; 
Stathopulos et al., 2003]. So far, 18 loci have been found linked to FALS: 
among them 15 loci (ALS1-15) are associated with typical ALS, whereas two 
loci (ALS16 and C9ORF72-mediated) are associated with FTD, in fact they are 
also named ALS-FTD1 (ALS16) and ALS-FTD2 (ALS-C9ORF72-mediated). 
The fact that mutations in a locus can be associated to ALS and FTD clinical 
symptoms suggest that different neurodegenerative diseases are characterized 
by the alterations of the same molecular processes. The presence of common 
molecular pathways makes the study of a neurodegenerative disease more 
fruitful, perhaps, as the study of a disease may illuminate the pathogenesis of 
another disease and designing therapies may become easier as well. Now 16 
ALS causative genes have been identified in these loci so far, they are listed in 
Table 1. However, the genetic cause of the majority of the ALS cases is still 
unknown. The identification of new ALS causative genes by molecular analysis 
of ALS patients can spot the protein that is altered in the disease. However, this 
approach is important, but not sufficient to pin-point the molecular pathway 
that is altered into the disease. In fact, the identification of the interacting 
partners of the protein mutated, and following genetic validation and functional 
analysis of the interaction can clarify the molecular pathways in which the 
protein is involved in normal conditions. Understanding how a particular 
cellular process works in normal conditions can help in elucidating why 
alteration of that pathway leads to such dramatic manifestations as in the case 
of ALS. In my PhD work, the interaction between VAPB, a protein found 
mutated in a particular type of ALS, and Sac1, is the starting point to identify 






Genes and Loci associated with ALS pathogenesis: 
 
Disease Locus Gene Reference 
ALS1 21q22.21 Superoxide dismutase 1 
(SOD1) 
Rosen, 1993 
ALS2 2q33 Alsin (ALS2) Yong et al., 2001 
ALS3 18q21 ?  
ALS4 9q34 Senataxin (SETX) Chen et al., 2004 
ALS5 15q15.1-q21.1 Spatacsin (SPG11) Orlacchio et al., 2010 
ALS6 16p12  Fused in sarcoma (FUS) Kwiatkowski et al., 
2009 
Vance et al., 2009 
ALS7 20ptel ? Sapp et al., 2003 
ALS8 20q13.33 VAMP-associated protein 
B (VAPB) 
Nishimura et al., 2004 
ALS9 14q11 Angiogenin (ANG) Greenway et al., 2006 
ALS10 1p36 Tar-DNA-binding protein 
(TDP-43) 
Sreedharan et al., 2008 
ALS11 6q21 Poliphosphoinositide 
phosphatase (FIG4/Sac3) 
Chow et al., 2009 
ALS12 10p15 Optineurin (OPTN) Maruyama et al., 2010 
ALS13 12q24 Ataxin-2 Ross et al., 2011 
ALS14 9p13 Valosin-containing protein 
(VCP) 
Johnson et al., 2010 




9p13 σNon-opioid receptor1 
(SigmaR1) 
Al-Saif et al.2011 






Hosler et al., 2009 
ALS18 17p13.2 Profilin 1 (PFN1) Wu et al., 2012 
Table 1. Genes and loci implicated in ALS pathogenesis 
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1.3 Drosophila as a model organism to study neurodegeneration 
 
Drosophila has become a useful animal model with which to uncover and 
characterize molecular pathways that are perturbed in human diseases [Marsh 
and Thompson, 2006]. The findings emerging from research carried out in fruit 
flies can help in determining new therapeutic targets [Marsh and Thompson, 
2006]. Several reasons highlight why Drosophila is exploited as an 
experimental system in which to study human pathological processes. First of 
all, the majority (75%) of the human disease-related genes have a homologue in 
fruit flies. In addition, the majority of these genes are involved in neurological 
and neurodegenerative impairments suggesting that many cellular pathways in 
the nervous system were conserved through evolution [Robin et al., 2000; 
Fortini et al., 2000; Reiter et al., 2001].  
 
Moreover, Drosophila also has the advantages of having a rapid generation 
time, of being easy to rise in the lab, and importantly, of being very prolific, 
and the genetics become easier when the animal has a large progeny [Cauchi, 
and van den Heuvel, 2006]. Furthermore, several genetic tools have been 
developed which allow researchers to control the spatiotemporal expression of 
target genes in various Drosophila tissues. I will introduce the basic genetic 










1.3.1 The UAS/Gal4 system 
 
 
Figure 1. The UAS-GAL4 system. Figure adapted from St.Johnston 2002. 
 
A useful tool that has been employed to precisely regulate gene expression is 
the binary UAS/Gal4 system (Fig. 1) [Brand and Perrimon, 1993]. Here two 
transgenic fly strains are crossed to each other. One comprises a tissue- and/or 
time-specific promoter (driver) upstream of the gene encoding the yeast Gal4 
transcription factor. The second Drosophila strain has a GAL4-responsive 
Upstream Activator Sequence (UAS), located upstream the target gene. The 
cross between these two Drosophila strains will generate flies that direct the 
expression of the protein encoded by the target gene in the desired tissue and at 
the desired developmental stage, under the control of the GAL4 driven 
enhancers  [Brand and Perrimon, 1993; Brand and Darmand, 1995].  
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1.3.2 The Drosophila larval Neuromuscular Junction 
 
A number of processes such as structural and functional synaptic plasticity, 
neurotransmitter release, and synapse physiology and ion channel function 
involve molecules that are highly conserved between Drosophila and humans 
[Fortini et al., 2000]. Thus, Drosophila is a suitable animal model for the study 
of these pathways. In particular, the Drosophila larval Neuromuscular Junction 
(NMJ) is a genetic model system that has played and still plays an important 
role in the study of cellular pathways regarding the neuroscience field [Ruiz-
Canada and Budnik, 2006]. The reason why this genetic model system is useful 
is that the synapses at the NMJ can respond to a number of changes [Griffith 
and Budnik, 2006]. In addition, the easy accessibility, the simplicity, the easy 
manipulation by several genetic tools make the Drosophila larval NMJ a 
powerful system [Ruiz-Canada and Budnik, 2006]. The synapse is also where 
some of the earlier symptoms of motor neuron diseases are thought to occur 
[De Vos et al., 2008; Saxena and Caroni, 2007; Plowey and Chu, 2011]. This 
makes the NMJ quite a useful experimental model in the study of 
neurodegenerative diseases. 
 
The larval body wall muscle is made up of abdominal segments and each 
abdominal segment is made up of two hemisegments. Each hemisegment 
comprises 30 skeletal muscles. The organization of these skeletal muscles is the 
same in each hemisegment. [Ruiz-Canada and Budnik, 2006]. This reiterated 
and highly stereotyped organization is useful in the sense that makes possible a 
careful and detailed phenotypic analysis.  
 
1.3.3 The adult Drosophila eye 
 
Several cellular pathways have been genetically dissected by using the adult 
Drosophila eye, including cell death pathways, the different steps of the cell 
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cycle, and growth factor signaling mediated by tyrosine kinase receptor 
[Agapite and Steller, 1997; Tanenbaum et al., 2000; Wolff et al., 2007]. 
Interestingly, the cellular pathways involved in eye development, often affect 
the photoreceptors, which is a specialized type of neuron that converts light into 
neuronal activity [Warrick et al., 1998]. Many neurodegenerative conditions are 
caused by deleterious mutations that often cause massive neuronal death, which 
can be lethal for the animal. However, by directing the expression of a mutant 
gene specifically in the eye, lethality can often be avoided, as only the 
photoreceptor neurons will be impaired. These neurons are not required for 
fertility or viability, thereby allowing neurodegeneration studies to be 
conducted over time in living flies.  
 
The photoreceptors are packed in groups of eight, and each group is called an 
ommatidium [Jackson et al., 1998]. The adult Drosophila eye comprises 800 
ommatidia, which are regularly arranged. Any impairment in cellular pathways 
implicated in either differentiation or cell-fate determination can be easily 
observed in the eye [St. Johnston 2002]. The extent of any disruption is directly 
related to the number of ommatidia that are damaged. Disruption can result in a 
‘rough-eye phenotype’, which can be easily scored using a dissecting 
microscope on living flies. This straightforward method is typically used in 
screens aimed at identifying genetic interactors of a target gene by 
overexpressing either wild type or mutated proteins specifically in the eye [St. 
Johnston 2002].  
 
1.4 VAPB- induced Amyotrophic Lateral Sclerosis (ALS type 8) 
 
ALS type 8 is a subtype of ALS that is associated with mutations in human 
VAPB (hVAPB) gene [Nishimura et al., 2004]. ALS8 sufferers present lower 
motor neuron lesions that are sometimes associated with postural tremor and 
bulbar palsy as clinical features [Nishimura et al., 2004]. All ALS8 cases are 
associated with an onset of the disease symptoms between the third and fifth 
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decade of life [Nishimura et al., 2004; Chen et al., 2010; van Blitterswijk et al., 
2012]. ALS type 8 patients also present the major hallmarks of Amyotrophic 
Lateral Sclerosis including cytoplasmic protein aggregates in motor neurons, 
motor neuron death and impaired movements [Ferraiuolo et al., 2011]. 
Cytosolic inclusions containing the disease protein, are characteristic of many 
neurodegenerative diseases, such as ALS, AD, HD and PD [Ross and Poirier, 
2005].  
 
Interestingly, problems in lipid metabolism were reported to be associated with 
ALS8 cases. In fact, high levels of triglycerides and cholesterol were observed 
in ALS8 patients [Marques et al., 2006]. In addition, altered energy metabolism 
was found to be a characteristic not only of ALS8, but also a feature of ALS in 
general. In particular, ALS patients present high lipid levels and increased 
energy expenditure was observed in ALS patients [Dupuis et al., 2008]. SOD1 
and TDP-43 transgenic murine models of ALS also presented 
hypermetabolism, as ALS patients, but low levels of lipid in the blood [Dupuis 
et al., 2011]. Indeed a diet high in lipid content leads to increased survival in 
SOD1 mouse model [Dupuis et al., 2004]; and hyperlipidemia is a protective 




associated proteins (VAPs)  
 
VAP proteins (VAPs) are type II integral membrane proteins, thus, they pass 
only once through the membrane and the C-terminal region of the protein faces 
the ER lumen [Lev et al., 2008]. A high throughput yeast two-hybrid screen 
performed to uncover interacting proteins of VAMP/synaptobrevin in Aplysia 
californica identified a VAP family member (aVAP-33). The role of this VAP 
protein was linked to neurotransmitter release, as anti-VAP antisera inhibited 
neurotransmitter release in cultured neuronal cells binding and blocking  
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aVAP-33 [Skehel et al 1995].  
 
Structurally, VAP proteins share a common overall domain organization across 
several species [Lev et al., 2008]. The main domains in VAPs are the 
following: the amino-terminal major sperm protein (MSP) domain, a coiled-
coil domain (CCD), and a carboxyl terminal transmembrane domain (TMD) 
(Fig. 2) [Skehel et al 2000]. The N-terminal MSP 100-aa domain faces the 
cytoplasm and it shares 45% similarity and 25% identity to the nematode MSP 
proteins (MSPs) [Nishimura et al 2004].  MSPs are proteins abundantly 
expressed in the amoeboid sperm cells of nematodes where they drive the 
movement of sperm [Roberts and Stewart, 1995]. The forward movement of 
these cells is obtained by cyclical polymerization and depolymerization of non-
polar filaments formed by MSPs [Tarr and Scott, 2005]. In C. elegans, oocyte 
meiotic maturation and ovarian muscle contractions are stimulated by MSPs 
through the antagonization of the ephrin/Eph receptor signaling [Miller et al., 
2003]. 
 
hVAPA (27.3 kDa and 242 aa) is encoded by a gene on chromosome (chr.) 18 
and represents the first human VAP protein to be characterized [Weir et al 
1998]. hVAPA shares 68% identity with hVAPB (27 kDa and 243 aa) encoded 
by the hVAPB gene on chromosome 20. hVAPB has a splice isoform known as 
hVAPC (11 kDa and 98 aa) that lacks the putative TMD and CCD. In the same 
study hVAPB was defined as the actual human homologue of aVAP-33 after 
the analysis of the binding properties of hVAPA, hVAPB and hVAPC proteins 
[Nishimura et al., 1999]. aVAP-33 homologues have also been identified in 
other species such as C. elegans, Drosophila, mice, rats, and plants [Skehel et 
al., 1995; Kagiwada et al., 1998; Nishimura et al., 1999; Skehel et al., 2000; 
Pennetta et al., 2002] suggesting that VAP proteins are evolutionarily 
conserved. The evolutionary conservation of these proteins suggests that they 
play a fundamental role in cells. Mammalian VAPA and VAPB are expressed 
in all tissues [Nishimura et al., 1999], similar to the expression data observed in 
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Aplysia californica [Skehel et al 1995].  
 
The MSP domain contains a conserved stretch of 16 amino acids, named ‘VAP 
consensus sequence’ (Fig. 2A). This consensus sequence is located at position 
41-59 of the human protein and it is present in the MSP domains of all the 
VAPs, but not in the MSP proteins [Lev et al., 2008]. The ‘VAP consensus 
sequence’ is directly implicated in the interaction with the di-phenylalanine in 
acidic tract (FFAT) motif, together with CCD and TMD of VAPs that expose 
hydrophobic patches that seal the binding between VAPs and FFAT motif-
containing proteins [Kim et al., 2010]. The FFAT binding motif will be 
discussed more extensively later in this section.  
 
Intriguingly, the two ALS8 mutations identified in hVAPB protein are located 
in the ‘VAP consensus sequence’ [Nishimura et al., 2004] and the crystal 
structure of the VAP-FFAT motif interaction has been resolved, identifying 
T46 as one of the crucial residues of VAP proteins for binding the FFAT motif 
[Kaiser et al., 2005]. 
 
In Drosophila, C. elegans, and mammals, the MSP domain of VAPs has been 
proposed to be cleaved and secreted from the cell to function in extracellular 
signaling through the interaction with membrane receptors such as Ephrin 
(Eph) receptor [Tsuda et al., 2008], SAX3-Robo receptor, and CLR1/Lar 
receptor [Han et al., 2012]. In particular, the last two receptors are involved in 
regulating the mitochondrial arrangement on I-bands, besides the regulation of 
other cellular functions, in muscles in C. elegans. Interestingly, an ALS8 
mutant allele of VAPB inhibits the MSP domain secretion, suggesting that this 
pathogenic mutation has a cell non-autonomous effect, because the motor 
neuron cells expressing the mutant allele of VAPB cause other cells, such as 
the muscle cell, to exhibit a mutant phenotype [Tsuda et al., 2008].  
 
The central 44-aa CCD (Fig. 2A) has been found in all t-SNARE protein family 
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members, in fact it is also known as ‘t-SNARE domain’ [Weimbs et al., 1997], 
and also in vesicular transport proteins [Nishimura et al., 1999]. This CCD has 
been described as a motif that mediates protein-protein interactions as well as 
having a role in homo-dimerization [Weimbs et al 1997; Soussan et al 1999].  
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Figure 2. Schematic view of the domain organization of VAPs. (A) Three domains in are conserved through all the VAPs: the N-terminal MSP domain 
(1-125aa), the CCD (158-211 aa) and the C-terminal TMD (220-243 aa). (B) The MSP domain of VAPs has a 16-aa VAP consensus sequence (42-59 aa). 
The 16-aa motif present in its sequence highly conserved amino acids. Two out of three ALS8 mutations affect two amino acids included in this motif 
(T46 and P56). (C) TMD is highly conserved through different species and the recently identified ALS8 mutation affects an amino acids included in this 
domain (V234). The TMD contains a Dimerization Motif. The sequence that creates the dimerization motif is made of “small-aaXXXsmall-aa”. Thus, it is 
often represented by either “GxxxG” or “SxxxG” aa sequences [Schneider et al., 2004]. GxxxG sequence is present in hVAPB, whereas SxxxG is placed 
into the TMD of the Drosophila protein. Interestingly, the dimerization motif is not completely conserved in the yeast homologue of hVAPB. This Figure 
adapted from Lev et al., 2008.  
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Finally, there is a C-terminal TMD acting as a membrane anchor [Nishimura et 
al., 2004]. Two glycines separated by three amino acids (GxxxG) form a 
dimerization motif [Kim et al., 2011]. The GxxxG motif localizes to the TMD 
of VAPB in mammals [Russ et al., 2000]. The TMD domain of hVAPB 
contributes to VAPB dimerization and oligomerization [Kim et al., 2011]. The 
VAPs are predominantly localized to the endoplasmic reticulum (ER) 
membranes, but can also be detected in the perinuclear region of the cell and at 
the plasma membrane [Kagiwada and Hashimoto, 2007].  
 
VAPs have been implicated in microtubule dynamics in Drosophila and in 
mammals. The Drosophila orthologue of hVAPB (DVAP) is abundantly present 
in the Drosophila larval NMJ. Microtubule dynamics in the presynaptic 
compartment is required to control the bouton budding. The presynaptic 
morphology is highly perturbed in loss-of-function flies for DVAP showing 
fewer but bigger boutons. Conversely, more but smaller boutons are observed in 
larval NMJs from strains overexpressing DVAP. This protein seems to facilitate 
the formation of microtubule (MT) loops inside new forming boutons mediating 
the interaction between MTs and the plasma membrane [Pennetta et al., 2002]. 
In addition, VAPB together with the interacting partner Nir3 control 
microtubule dynamics in mammalian cells [Lev et al., 2008]. When these two 
proteins are overexpressed in mammalian cells two phenotypes are observed: 
perturbation of ER membrane morphology and accumulation of thick 
microtubule bundles around the ER. This evidence suggests that VAPB forms a 
complex with MTs and Nir3 [Amarilio et al., 2005].  
 
1.5.1 VAP proteins are plasma-membrane-lipid sensors 
 
Changes in the lipid composition of the plasma membrane can be ‘sensed’ by 
VAP proteins directly or indirectly through the interaction with other proteins 
[Loewen et al., 2004]. VAP proteins could ‘sense’ levels of specific PIPs by 
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directly binding them. In fact, a phosphoinositide (PI) binding domain has been 
identified in the MSP domain of Scs2p in yeast. In particular it overlaps with the 
‘VAP consensus sequence’ that is directly implicated in the interaction with the 
FFAT motif. This domain interacts with phosphoinositide-4,5-bisphosphate 
(P(4,5)P2) and with phosphoinositide-4-phosphate (PI4P) in vitro. The partial 
overlapping between the ‘VAP consensus domain’ and PIP binding domain 
suggest that PIP levels regulate the interaction between VAP proteins and the 
FFAT domain [Kagiwada and Hashimoto, 2007]. Interestingly, a DVAP 
interacting protein Sac1 regulates the PI4P turnover [Mayinger et al., 1995].  
 
VAP proteins can also ‘sense’ lipid molecules through other proteins that bind 
lipid molecules [Loewen et al., 2004]. For instance in yeast Opi1p is an 
interacting partner of Scs2p and binds the phosphatidic acid (PA). Low levels of 
PA lead to the translocation of Op1p from the ER to the nucleus. PA is required 
for the synthesis of PIPs. The dissociation of Opi1p from Scs2p at the ER is a 
consequence of the production of PIPs that leads to decreased levels of PA. 
Thus, inositol synthesis is inhibited by Opi1p that dissociates from Scs2p, and 
translocates to the nucleus where it inhibits the transcription of INO1 gene 
[Loewen et al., 2004].  
 
VAP proteins localize to the ER that is the major site of synthesis of lipids. In 
addition, they interact with proteins that sense lipids, proteins that bind lipids 
and proteins that are involved in the metabolism of lipid molecules [Lev et al., 
2008]. This suggests that VAPs can also play a role in lipid transport. The 
involvement of VAPs in lipid transport is demonstrated by their interaction with 
the cytosolic Ceramide Transfer Protein (CERT). This protein is required to 
transport ceramide from the ER to the Golgi complex [Hanada et al., 2003]. 
This lipid transfer protein localizes to the ER through its interaction with VAP, 
and localizes to the Golgi complex through the interaction with PI4P. The 
importance of VAPs in the function of CERT is proved by the fact that 
mutations in the FFAT motif of CERT inhibit its interaction with VAPs, 
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negatively affecting the transport of Ceramide between ER and Golgi [Kawano 
et al., 2006].  
 
1.5.2 VAP proteins and the Unfolded Protein Response 
 
VAP proteins are implicated in the Unfolded Protein Response (UPR) in yeast. 
In fact, Scs2p null mutant strains of C. elegans are sensitive to UPR following 
the ER stress induced by tunicamycin [Kagiwada et al., 1998]. Tunicamycin 
induces ER stress through the inhibition of N-linked glycosylation [Samali et 
al., 2010]. Nevertheless, overexpression of Scs2p in a null-background for hac1 
protein suppresses the inositol auxotrophy phenotype [Nikawa et al., 1995]. 
Hac1 is a transcription factor that binds the UPR-elements that are present in the 
promoters of UPR-target genes. This transcription factor is activated by IRE1 in 
response to the accumulation of unfolded proteins in the ER lumen. IRE1 is an 
ER transmembrane protein that has also an endoribonuclease activity 
[Kagiwada et al., 1998]. This protein moves to the nucleus when it senses the 
accumulation of unfolded proteins in the ER. Ire1 in the nucleus activates Hac1 
transcription factor.   
 
1.5.3 ALS8-causative mutations in hVAPB  
 
VAP proteins are implicated in a number of cellular functions and the majority 
of the pathways in which VAP function is implicated involve lipid molecules. A 
better understanding of all these pathways in which VAP proteins are implicated 
and how they are connected to each other can help in understanding the role of 
VAPs in ALS8 pathogenesis.   
 
To date, three disease-causing mutations have been identified in the human 
VAPB (hVAPB) gene: the first mutation to be reported causes the change of a 
proline residue at position 56 to a serine (P56S) [Nishimura et al., 2004]; the 
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second mutation is a threonine-to-isoleucine substitution at position 46 (T46I) 
[Chen et al., 2010]; the third mutation is a valine-to-isoleucine substitution at 
position 234 (V234I) [van Blitterswijk et al., 2012]. The first two mutations 
affect two conserved amino acids placed in the ‘VAP consensus sequence’ in 
the MSP domain of hVAPB (Fig. 2B), whereas the third mutation affects a 
conserved amino acid of the TMD of hVAPB (Fig. 2C). However, a valine at 
the position 234 of hVAPB is not found in Aplysia and S. cerevisiae (Fig. 2C). 
Thus, this amino acid is less conserved than the threonine-46 and proline-56. 
Nevertheless, the V234I substitution was reported to be in association with 
repeat expansion in C9orf72 gene. The presence of hexanucleotide repeat 
(GGGGCC) expansion in the intron of C9orf72 gene has been found to be the 
major cause of ALS-FTD, so far [De-Jesus-Hernandez et al., 2011; Renton et 
al., 2011]. In addition, this repeat expansion has been reported also in FALS and 
FTD sufferers [van Blitterswijk et al., 2012]. The functional consequences of 
the mutations in hVAPB protein have not been investigated yet, because, to 
date, mutations in hVAPB are still considered a rare genetic cause of ALS8.   
 
ALS8 Drosophila models for T46I and P56S mutations have been generated. 
The P56S and T46I in hVAPB correspond to residues P58S and T48I in DVAP, 
respectively. These diseased flies present the major hallmarks of the disease 
[Chai et al., 2008; Chen et al., 2010]. DVAP immunoreactive aggregates were 
observed in the brains and nerves of third instar larvae expressing DVAP-P58S 
pan-neuronally, and also in brains of third instar larvae expressing DVAP-T48I 
in the nervous system by immunohistochemical analysis [Chai et al., 2008; 
Chen et al., 2010]. In addition, DVAP immunoreactive aggregates were also 
observed in skeletal muscles of Drosophila larvae expressing DVAP-T48I 
mutant allele [Chen et al., 2010]. This last evidence has proved that the function 
of muscles is not only affected as a consequence of denervation, but also 
because the muscle is a direct site of the effects of mutant allele of DVAP 
expression. Moreover, neurodegeneration was observed in the Drosophila adult 
eye of flies expressing DVAP-T48I selectively in the visual system [Chen et al., 
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2010]. Impaired movements and paralysis are some of the most common and 
earliest symptoms in ALS patients, and are also present in ALS experimental 
models [Mulder, 1982; Talbot, 2002; Hart et al., 2006]. In the fly model of 
ALS8, third instar larvae bearing DVAP-P58S showed a decreased frequency of 
peristaltic contractions, thus presenting locomotion defects when compared to 
control animals [Chai et al., 2008]. Rhythmic contractions of the body wall 
musculature are responsible for forward locomotion in Drosophila larvae. The 
central pattern generator (CPG) network in the nervous system gives rhythmic 
burst to the motor neurons causing rhythmic contraction waves [Caldwell et al., 
2003].  
 
Interestingly, hVAPB was found not only associated to ALS8, but also to 
Fronto-Temporal-Dementia-with-Parkinsonism-linked-to-chr.17 (FTDP-17). In 
fact, a murine model for FTDP-17 presents high levels of VAPB. In addition, 
neurodegeneration in a FTD Drosophila model is decreased when LOF mutant 
alleles DVAP are expressed [Karsten et al., 2006]. Finally, ALS characteristic 
symptoms were observed in some FTDP-17 patients [Lomen-Hoerth, 2004]. 
Thus, hVAPB is involved in typical and atypical ALS. 
 
1.6 Drosophila VAPB (DVAP) 
 
Drosophila has three VAPs which are named farinelli, DVAP-33B, and DVAP. 
They respectively share 39%, 18%, and 40% identity with aVAP-33, 
respectively [Lloyd et al 2000]. In particular, DVAP is the functional homolog 
of hVAPB in Drosophila, as defects due to DVAP loss-of-function can be 
rescued by both hVAPB [Chai et al., 2008]. For brevity, DVAP will be known 
in this thesis as DVAP herein. The DVAP gene is located on chromosome X, at 
cytological position 3F5-6, has seven exons and the encoded protein has a 
predicted molecular weight of 35 kDa. DVAP protein presents three 
characteristic structural domains of VAPs the MSP domain, CCD and TMD 
(Fig. 2A). Interestingly, the TMD does not present the dimerization motif 
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‘GxxxG’ that is present in the TMD domain of VAPs in mammals, C. elegans, 
A. californica (Fig. 2C) [Lev et al., 2008].  
 
DVAP is ubiquitously expressed through the different developmental stages 
[Pennetta et al., 2002]. DVAP localizes mainly to the sub-cellular membranes, 
although some of the protein is also detected in the cytoplasm [Pennetta et al., 
2002]. At the NMJ of third instar larvae, DVAP is present at both the pre- and 
postsynaptic compartments of the glutamatergic synaptic target muscle fibres 
[Pennetta et al., 2002]. Presynaptically, DVAP is located in the periactive zones 
where proteins required for synaptic growth are clustered [Pennetta et al., 2002; 
Sone et al., 2000]. Moreover, during active synaptic bouton budding DVAP 
redistributes itself in the boutons, becoming enriched at the base of the bud of 
the newly forming boutons, and at the tip of the incipient bouton at the 
beginning of bouton budding. In addition, there is association between DVAP 
and MTs in neurons [Pennetta et al., 2002]. DVAP appears to play a role in 
connecting MTs to the plasma membrane at the presynaptic compartment, to 
foster new bouton formation [Pennetta et al., 2002].  
 
1.7 VAP interacting proteins 
 
VAP-interacting proteins can provide clues about the function of VAP proteins 
in cells [Lev et al., 2008]. However, the interacting partners of VAPs are 
involved in many diverse intracellular functions that place VAPs at crossroads 
for different pathways and complicate the dissection of the role of VAP in 
neurodegeneration. To date, many proteins have been shown to bind to VAP 
proteins in different organisms [Lev et al., 2008]. The VAPs interacting partners 
include proteins implicated in a number of cellular functions as it has previously 
been mentioned in the introduction section [Skehel et al., 2000; Pennetta et al., 
2002; Nikawa et al 1995; Kagiwada et al., 2003; Kawano et al., 2006; Brickner, 
and Walter, 2004; Kanekura et al., 2006; Skehel et al., 1995; Soussan et al., 
1999; Loewen et al., 2003].  
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1.8 Interaction between VAP and proteins involved in lipid metabolism 
and homeostasis 
 
The interacting partners of VAPs can be classified into four groups according to 
their subcellular role: MT organization, unfolded protein response (UPR), lipid 
metabolism and lipid transport, and membrane trafficking [Lev et al., 2008]. 
These interactions have been identified through a number of in vitro binding 
assays, such as ‘yeast two-hybrid’, co-immunoprecipitation (Co-IP), in vitro 
pull down, and affinity capture assay [Lev et al., 2008]. Thus, the functional 
relevance of these interactions needs to be examined. To date, the interactions 
between VAPs and proteins involved in lipid regulation are the best 
characterized [Lev et al., 2008].  
 
The proteins involved in lipid metabolism and lipid transport interacting with 
VAPs include proteins containing a FFAT motif, as well as proteins that do not 
[Gavin et al., 2002]. The FFAT motif is a consensus sequence (EFFDAxE) that 
is directly involved in the interaction with VAP proteins [Wyles et al., 2002; 
Loewen et al., 2003]. Many VAP interacting proteins seem to interact with VAP 
to localize at the cytoplasmic surface of the ER and at vesicles. The lipids are 
assembled in the ER, this could explain why the ER is a crucial lipid sensing 
organelle [Voeltz et al., 2002], and, in turn, why many proteins implicated in 
lipid synthesis localise to this organelle.  
 
1.8.1 VAP-interacting proteins not containing a FFAT motif in their 
sequence 
 
The No-FFAT-motif proteins that are involved in lipid metabolism and that 
interact with VAPs are Sac1 phosphatase and Stt4 kinase. These two enzymes 
are required for the metabolism of a subgroup of Phosphoinositide phosphates 
(PIPs): PI4P. The PIPs are phosphorylated derivatives of the phospholipid 
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phosphatidylinositol, and they recruit molecules to the cytosolic surface of cell 
organelles and of the plasma membrane [McCrea, and De Camilli, 2009]. These 
lipid molecules are of considerable interest, as they are involved in a wide 
variety of processes [Mc Crea, and de Camilli, 2009].  
 
PIPs have an important role in modulating signal transduction at the plasma 
membrane [Di Paolo and De Camilli, 2006]. PI(4,5)P2 is a PIP specie that 
localizes to the PM. This PIP is generated mainly from phosphorylation of 5-
OH of PI4P by type I PI-kinases. The PM-PI4P is generated both at specific 
sites and also by transport from recycling organelles from Golgi membranes by 
membrane carriers [Odorizzi et al., 2000]. PI(4,5)P2 can be used as substrate by 
three different types of enzymes: phospholipases, phosphatases and PI3 kinases. 
The metabolites that are obtained by the activity of phospholipase C and 
phospholipase A2 amplify signalling, whereas 5-phosphatases turn off 
signalling. PI(3,4,5)P3 obtained by the activity of PI3kinases on PI(4,5)P2 also 
propagate signalling [Cantley et al., 2002]. In fact, PI(3,4,5)P3 recruits effectors 
to the PM that activate a number of cellular pathways. Signalling pathways 
including the Tor pathway, are regulated by effectors as PDK and AKT/PKB 
kinases, whereas the actin cytoskeleton is remodelled by GAP and GEF 
effectors [Cremona et al., 1999]. In turn, PI(3,4,5)P3 can face two different 
dephosphorylation events leading to two outcomes. Dephosphorylation of 
PI(3,4,5)P3 by 5-phosphatases induces prolongation of signalling, whereas 
dephosphorylation of PI(3,4,5)P3 by 3-phosophatases leads to attenuation of 
signalling [Majerus et al., 1999].  
 
PIPs regulate different aspects of the actin cytoskeleton: the actin nucleation, 
the actin filaments elongation and the interaction between actin filaments and 
the PM [Di Paolo and De Camilli, 2006]. PI(4,5)P2 in association with Cdc42 
GTPase bind and activate Neural-Wiskott Aldrich syndrome protein (N-
WASP), that is normally present in an auto-inhibited conformation. Its 
interaction with PI(4,5)P2 and Cdc42 induces a conformational change that 
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allows this protein, in turn, to bind and activate the Actin-Related-Protein 
(ARP)2/3-mediate the actin polymerization [Pollard et al., 2003; Rohatgi et al., 
2000]. In addition, actin filament elongation is facilitated by PI(4,5)P2 that 
induces the dissociation of CapZ and gelsolin capping proteins at the plus ends 
of the actin filaments [Yin et al., 2003]. The function of adaptor proteins 
between actin filaments and membranes are also regulated by PI(4,5)P2 in sites 
of adhesion between cells or between cells and matrix. PI(4,5)P2 binds a FERM-
domain adaptor protein that enhances its affinity for integrins [Di Paolo, and De 
Camilli, 2006; Ling et al., 2002].  
 
PIPs are implicated in phagocytosis as a consequence of the induction of actin 
nucleation induced by PI(4,5)P2 as described above. Actin polymerization is 
required during phagocytosis events because the foreign particle has to be 
incorporated in the cell by the formation of cell protrusions [Botelho et al., 
2004]. PIPs are also implicated in endocytosis, in fact, they bind endocytic 
factors such as clathrin adaptors and endocytic factors required for the fission 
reaction [Wenk et al., 2004]. 
 
Phosphatidylinositol is synthesised in the ER before being carried to other 
intracellular membranes by proteins which transfer phospholipids [McCrea and 
De Camilli, 2009]. Seven PIPs were reported, so far, and they differ from each 
other depending on the combination of phosphates at three different positions, 
the 3-OH, the 4-OH and the 5-OH, of their inositol head group. The importance 
of the position of the inositol head of each PIP is shown by the fact that each 
phosphatidylinositol phosphate has a specific function and intracellular 
localization [Volpicelli-Daley and De Camilli, 2007]. Specific PIPs are 
localised to different intracellular organelles [Mc Crea and de Camilli, 2009]. 
The addition and removal of the phosphate groups from inositol derivatives is 
catalysed by lipid kinases and lipid phosphatases, respectively, and Sac1 
domain-containing phosphatases are involved in the generation of several of 
these derivatives [Mc Crea and de Camilli, 2009].  
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PI4P lipid is mainly generated at the Golgi membranes where it also localizes 
[Mayinger, 2009]. The Golgi apparatus function depends on PI4P. In particular, 
in yeast it is implicated in the anterograde trafficking of proteins such as chitin 
synthases, Hsp150 and invertase, and also in the trafficking from the Golgi to 
the cell periphery [Walch-Solimena et al., 1999; Audhya et al., 2000; Schorr et 
al., 2001]. This role of PI4P has been also described in mammals [Walch-
Solimena et al., 1999; Hama et al., 1999; Audhya et al., 2000; Schorr et al., 
2009]. The proteins that interact with PI4P, bind this lipid molecule through the 
Pleckstrin homology (PH) domain. The PI4P interacting proteins include two 
classes of proteins: the first one encompasses no-clathrin-mediated lipid transfer 
proteins such as FAPP2 (Four-phosphate adaptor protein-2), OSBP (Oxysterol-
binding protein) and CERT. The second class of PI4P binding proteins 
implicated in the clathrin-mediated transport such as Golgi-localized, γ-ear-
containing ADP-ribosylation factor-binding proteins (GGAs) and clathrin 
adaptor protein complex-1 (AP1) [D’Angelo et al., 2008]. The formation of 
clathrin-coated vesicles is mediated by GGA and AP1 proteins at the endosomes 
and trans-Golgi network [Hinners, and Tooze, 2003].  
 
All together this evidence supports the idea that PIPs are crucial lipid molecules 
inside the cell, as they are implicated in a number of cellular functions. This 
suggests that an alteration in PIP turnover could lead to catastrophic 










1.8.1.1 Sac1  
 
 
Figure 3. Domain organization of the Sac1 proteins. (A) The hSac1 protein present a SAC 
domain (green) that include seven motifs. The first motif includes a leucine zipper motif 
(orange, 97-126 aa), whereas the sixth motif includes the phosphatase core (red, 389-396 aa). At 
the C-terminus of the protein two TM domains allow this protein to be anchored to the 
membrane. Finally a COP-I binding motif (blue, 587-593) is present at the C-terminal end. (B) 
Alignment among Sac1 proteins from different species shows that the leucine zipper motif is 
present in the human and murine proteins, but it is not observed in C. elegans and S. cerevisiae. 
In Drosophila only to leucines of the five leucines in the motif in the mammals Sac1. On the 
other hand the COP-I binding motif is present in mammals and Drosophila Sac1 proteins but not 
in C. elegans and S. cerevisiae. [Blagoveshchenskaya et al., 2008].  
 
Suppressor of actin-1 (Sac1) is a 67 kDa lipid phosphatase and belongs to the 
Sac1-domain containing protein family [Mayinger et al., 1995]. Other members 
include Sac2 (also known as INPP5f), Sac3 (also known as FIG4), and 
Synaptojanin 1 and 2 [Hughes et al., 2000]. Evidence from experiments 
performed in yeast reported that Sac1 localises to the Golgi complex and to the 
ER [Whitters et al., 1993; Nemoto et al., 2000].  This phosphatase family is 
highly conserved across all species and shares a domain, known as SAC 
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domain, at the N-terminal region. The Sac1 sequence includes also two TM 
domains at the C-terminus (Fig. 3).  
 
The SAC domain includes seven motifs, where the first one contain the Leucine 
Zipper motif and the sixth one the catalytic core (CX5R(T/S)) of the protein 
[Hughes et al., 2000] (Fig. 3A). Intriguingly, there are topological features of 
Sac1 that are conserved throughout the species such as the presence of the SAC 
domain and of the two TM domains [Blagoveshchenskaya et al., 2008]. On the 
other hand, the LZ motif seems to be a characteristic motif of the mammalian 
Sac1 although two leucines out of five are conserved in the Drosophila protein 
[Blagoveshchenskaya et al., 2008] (Fig. 3B). The LZ motif is required for 
oligomerization [Blagoveshchenskaya et al., 2008]. Coated protein-I (COP-I) 
binding motif seems to be present only in mammals (Fig. 3B) and it is required 
for the interaction with COP-1 [Blagoveshchenskaya et al., 2008].  
 
The CX5R(T/S) catalytic motif is involved in the removal of a phosphate-group 
from the position 4 of the inositol-head group of PIPs to regulate the turnover of 
these lipid molecules [Blagoveshchenskaya et al., 2008]. Nevertheless, in vitro 
Sac1 can also dephosphorylate Phosphoinositide-3-phosphate (PI3P) and 
Phosphoinositide-3,5-bisphosphate (PI(3,5)P2) [Guo et al., 1999]. In addition, 
PIPs are also required in priming of vesicles in endocytosis [Wiedemann et al., 
1998].  
 
The Sac1 gene was isolated during a complementation screen performed in S. 
cerevisiae in order to identify suppressor genes of mutations in the actin gene 
[Novick et al., 1989; Cleves et al., 1989]. Additionally, in yeast, defects in the 
actin cytoskeleton, caused by Stt4 null mutations, are partially rescued by Sac1 
null mutations [Gavin et al., 2002]. Moreover, yeast Sac1 has been described to 
directly interact with Vps74 protein [Wood et al., 2009]. The Drosophila 
Vps74, named GOLPH3, was proposed to act as a bridge between the Golgi 
complex and the actin cytoskeleton [Dippold et al., 2009]. In addition, yeast 
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Sac1 is also implicated in controlling the vacuole shape [Foti et al., 2001], and 
in sphingolipid metabolism in S. cerevisiae [Brice et al., 2009].  
 
In Drosophila Sac1 functions through the Jun N-terminal kinase (JNK) MAPK 
signalling pathway to regulate changes in cell shape during gastrulation [Wei et 
al., 2003]. This process is critical for embryonic development and survival, and 
loss of Sac1 function results in embryonic lethality [Wei et al., 2003]. In 
addition, a role for Drosophila Sac1 in the modulation of Hedgehog signalling 
has been reported. In fact, loss-of-function mutations in Sac1 induce 
localization of Smoothened (SMO) to the plasma membrane. The translocation 
of SMO to the PM is a step inducing activation of Hh signalling [Yavari et al., 
2010].  
 
Phosphoinositide phosphatases are thought to play a role in neurodegenerative 
processes when their function is impaired [Mc Crea and de Camilli, 2009]. 
Sac3/Fig4, the molecular cause of ALS11 [Chow et al., 2009], is a phosphatase 
that dephosphorylates PI(3,5)P2 substrates [Yuan et al., 2007]. A P-element 
insertion screen performed in Drosophila showed that Sac1 enhances the 
neurodegenerative phenotype in the adult eye caused by overexpression of 
Spinocerebellar Ataxia type 8 (SCA8) gene in all photoreceptor neurons 
[Mutsuddi et al., 2004]. The involvement of enzymes that regulate PIP levels in 
neurodegenerative processes means that these lipid molecules regulate 
fundamental processes at the nervous system.  
 
Sac1 is expressed in sensory neurons in the peripheral nervous system (PNS) 
and in Fascilin-II (FasII) positive axons in the central nervous system (CNS) 
where it was proposed to control axonal path-finding in Drosophila embryos 
[Lee et al., 2011]. FasII is the Drosophila orthologue of the synaptic adhesion 
molecule NCAM (neural cell adhesion molecule). It functions as a bridge 
between the pre- and postsynaptic membranes at the NMJ [Packard et al., 2003]. 
The synaptic morphology is perturbed when FasII function is impaired. 
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Decreased levels of FasII are associated with smaller boutons and shorter and 
fewer secondary axons [Stewart et al., 1996]. Complete loss-of-function 
mutations in fasII gene lead to retraction of the presynaptic boutons [Schuster et 
al., 1996]. In addition, Sac1 seems to mediate axon repulsion in the Slit/Robo 
pathway  [Lee et al., 2011].  
 
Finally, preimplantation lethality is observed in the presence of loss-of-function 
mutations in Sac1 [Liu et al., 2008]. In the same study Sac1 function was 
studied in HeLa cultured cells and disruption of mitotic spindle and of the Golgi 
complex was reported when Sac1 levels were decreased by RNAi approach.  
 
A protein-interaction map as a consequence of a high-throughput yeast two-
hybrid screen performed by Giot et al., [2003], showed that DVAP binds 
Drosophila Sac1. Interestingly, the Saccharomyces cerevisiae VAP proteins 
(Sc22p and Scs2p) are crucial in regulating the turnover of phosphoinositides-4-
monophosphate (PI4P) at contact sites between PM and endoplasmic reticulum 
(ER) to control Sac1 phosphatase activity in vitro and in vivo [Stefan et al., 
2011].  
 
1.8.1.2 Staurosporine- and temperature sensitive 4 (Stt4) protein  
 
Stt4 kinase is an enzyme that was identified in Saccharomyces cerevisiae during 
a genetic interaction screen designed to identify components of the protein 
kinase-C (PKC) pathway [Yoshida et al., 1994a]. Stt4 protein presents in its 
sequence one LKU (lipid kinase unique) domain and a PI4K (PI4-kinase) 
domain. The topological organization of this protein is conserved from 
Saccharomyces cerevisiae to mammals [Baird et al., 2008].  
 
Although this enzyme has a cytoplasmic localization, it is also required at the 
plasma membrane where it is anchored to trans-membrane proteins, to generate 
PI4P lipid from PI [Foti et al., 2001]. The PI4P pool of PM (PM-PI4P) can then 
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either function in activating transduction-signalling pathways, such as MAP 
kinase cascade and Hh signalling pathway or it can be further converted to 
PI(4,5)P2 by Mss4p (Multicopy Suppressor of Stt4) kinase [Audhya et al., 
2000]. The PI4P levels of the PM are modulated by Sac1 phosphatase, which 
converts PI4P into PI [Foti et al., 2001].  
 
The Stt4 kinase is linked to pathways that are regulated by changes in PM-PI4P 
levels and in Saccharomyces cerevisiae, PI4P pools at the PM are involved in 
the positive regulation of the MAP kinase cascade [Audhya and Emr, 2002]. 
Additionally, in Drosophila, the PI4P pools generated by Stt4 are involved in 
activating the Hh signalling pathway [Yavari et al., 2010]. Modulation of the Hh 
signalling pathway was also observed by studying the murine ortholog of Stt4 
protein in mouse fibroblasts [Yavari et al., 2010], indicating that this function is 
conserved in mammals. The phenotypes in yeast associated with mutations in 
Stt4 are altered integrity of wall signalling, that can be rescued by PKC1 over-
expression suggesting that Stt4 kinase plays a role in PKC1 pathway [Yoshida 
et al., 1994a, Yoshida et al., 1994b].  
 
Evidence of the direct interaction between Stt4 kinase and VAP proteins come 
from a large-scale affinity capture screen carried out in yeast aimed to identify 
multiprotein complexes carried out in yeast, which provides further evidence 
that VAP proteins are involved in regulating lipid metabolism [Gavin et al., 
2002]. Nevertheless, the interaction between these two proteins needs to be 
examined in vivo.  
 
1.8.2 VAP-interacting proteins containing a FFAT motif in their sequence 
 
In eukaryotes lipids are transferred through the cytosol between different sub-
cellular compartments using mechanisms that are independent from vesicular 
transport [Voelker et al., 2000]. This mode of lipid transfer is directed by lipid 
binding proteins [Wirtz et al., 1991]. A crucial requirement of these proteins is 
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their ability to bind to specific sub-cellular organelles. To achieve this, they 
possess motifs that allow them to interact with resident proteins at specific 
intracellular membranes. As the synthesis of the majority of lipid molecules 
occurs in the ER, this organelle has a crucial role in lipid trafficking [Baumann 
and Walz, 2001]. Additionally, biochemical assays confirmed that the ER 
compartment is involved in non-vecicular lipid transfer [Vance and Vance, 
1990; Voelker, 2000].   
 
The FFAT motif was characterized by studying the residues that are required for 
the interaction between Scs2p, the VAP yeast homologue, and the 
transcriptional regulator named Opi1p [Loewen et al., 2003]. The consensus 
sequence of the FFAT motif was determined as EFFDAXE. Later, VAP 
proteins were shown to interact with several FFAT-containing proteins that bind 
and transport lipids. These proteins include human homologues of ceramide 
transport protein (CERT) [Kawano et al., 2006], oxysterol-binding protein 
(OSBP) [Wyles et al., 2002], and phosphatidylinositol 
(PtdIns)/phosphatidylcholine (PtdCho)-transfer protein, Nir2 [Amarilio et al., 
2005]. More recently, VAP has been shown to interact with many other proteins 
involved in lipid metabolism with a “FFAT-like motif”, indicating that the 
consensus sequence may be more variable than previously thought [Mikitova & 
Levine, 2012]. 
 
In Saccharomyces cerevisiae, the site in VAPB that recognizes the FFAT motif 
was identified as a highly conserved 16-amino acid motif in the amino-terminal 
portion, within the MSP domain [Kaiser et al., 2005]. Surprisingly, MSP 
proteins do not contain in their MSP domain the FFAT- binding motif [Kaiser et 
al., 2005]. The crystal structure of the interaction between the FFAT motif and 
the FFAT-binding motif of the mouse VAPA has been determined [Kaiser et al., 
2005]. This model shows that four amino acids (Lys45, Thr47, Lys87 and Lys 
118) of the mouse VAPA sequence are responsible for making hydrophobic van 
der Waals contacts with the aliphatic side chains of the FFAT motif. This 
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FFAT-binding domain is present also in VAPB, and in addition Thr47, 
corresponding to Thr46 in human VAPB was found mutated in a group of ALS8 
patients [Chen et al., 2010]. Moreover, the capability of the Saccharomyces 
cerevisiae VAPB gene of rescuing the phenotype in scs2Δ mutant, is lost when 
the four residues are mutated [Loewen, and Levine, 2005]. These data support 
the idea that the FFAT-binding domain of VAPs is crucial for the correct 




Oxysterol binding protein (OSBP) is a cytoplasmic protein with a molecular 
weight of 95-110 kDa.  It belongs to the OSBP-related protein (ORP) family 
and was the first member of this highly conserved protein family to be identified 
[Taylor et al., 1985]. Subsequently, this protein was purified from rabbits and 
human where the cDNAs of these proteins were cloned [Dawson et al., 1989; 
Levanon et al., 1990]. Several homologues from different species have been 
determined for OSBP, as well as for the majority of ORPs [Lehto et al., 2001; 
Jaworski et al., 2001; Anniss et al., 2002].  ORPs from different species 
including mouse, rat, Drosophila, and C. elegans, were identified and 
characterized, with yeast and human ORPs receiving the most attention 
[Raychaudhuri et al., 2010]. Humans have 12 ORPs whereas yeast has only 7 
ORP members, which are named OSH1-7 [Lehto et al., 2001; Beh et al., 2001].  
 
All these ORPs possess the characteristic ORP motif (EQVSHHPP) as well as 
an ORP lipid-binding domain [Raychaudhuri et al., 2010]. Additional domains 
were also identified in the majority of these proteins including pleckstrin 
homology (PH) and FFAT domains. These two motifs were found conserved in 
ORPs through various species ranging from yeast to humans [Raychaudhuri et 
al., 2010].  
 
The PH domain (120 aa) is a domain which has been identified at first in 
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pleckstrin proteins, and was subsequently reported in many proteins that are 
associated with microtubules and involved in cell signaling [Haslam et al., 
1993; Mayer et al., 1993]. However, the interaction with phosphoinositide 
phosphate (PIPs) species is a very well studied functional characteristic of all 
the PH domains [Lemmon et al., 2000]. Each PIP isomer localizes specifically 
to an intracellular organelle [De Matteis et al., 2002], and PH-domain 
containing proteins can localize to specific subcellular membranes according to 
the PIP specie that is recognized by their PH domain [Hanada et al., 2009].  
 
The OSBP protein possesses a PH domain [Ridgway et al., 1992] that 
specifically interacts with the PIP isomers PI4P and PI(4,5)P2  [Hanada et al., 
2003; Levine and Munro, 2002; Godi et al., 2004]. Although OSBP is a 
cytosolic protein, it can relocate to the Golgi apparatus through the interaction 
with PI4P in response to an increase in 25-hydroxycholesterol (25-HOC), a 
cholesterol derivative, levels. The association of OSBP is made possible by the 
interaction of OSBP with 25-HOC [Lehto and Olkkonen, 2003]. The FFAT 
domain of OSBP mediates its interaction with VAP proteins [Loewen et al., 
2003; Kaiser et al., 2005], which was revealed during a yeast two-hybrid screen 
aimed at identifying new interactors of OSBP [Wyles et al., 2002].  
 
In yeast, VAPs and ORP1L colocalize at the contact sites between endosomes 
and ER membranes [Rocha et al., 2009]. VAPs, in association with Oxysterol-
binding homology (Osh) proteins, seem to play a role in the regulation of Sac1 
PI phosphatase function at the membrane contact sites [Stefan et al., 2011]. 
Sac1 is a PI4P phosphatase that also interacts with VAP proteins, although the 
domains responsible for this interaction have yet to be identified. Yeast VAPs 
seem to positively control the function of Osh3 at the contact sites between 
plasma membrane and endoplasmic reticulum. The Osh3 function that is 
regulated by Scs2p senses PI4P pools at the PM, which activates Sac1 at the ER 
[Stefan et al., 2011].  
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Two other yeast PI phosphatases, synaptojanin and myotubularin orthologs, 
named Sjl3 and Ymr1 respectively, are also regulated by the interaction 
between Scs2p and Osh7 proteins [Parrish et al., 2005]. Stefan et al., [2011] 
reinforced the idea that Oshs are PIPs sensors and that these proteins have the 




CERT, (also known as Goodpasture antigen binding-protein), is a 68 kDa 
cytoplasmic protein, that possesses an amino-terminal 120 aa PH domain [Raya 
et al., 1999; Raya et al., 2000], a central 250 aa serine-repeat (SR) region, a 
FFAT motif, and, a 230 aa ‘steroidogenic acute regulatory protein (STAR)-
related’ (START) domain in the C-terminal portion of CERT [Ponting et al 
1999]. It is a protein implicated in Ceramide transfer [Hanada et al., 2003] and 
was uncovered because of its ability to restore ceramide transport defects from 
the ER to the Golgi in a CHO (Chinese Hamster Ovary) mutant cell line 
[Hanada et al., 2003].  The localization of CERT at the ER depends on the 
interaction with VAPs, whereas its localization at the Golgi complex 
membranes depends on its interaction with PI4P through the PH domain. The 
human CERT protein appears to have a cytoplasmic distribution pattern, but it is 
enriched at the Golgi compartment [Kawano et al., 2006]. The Drosophila 
counterpart localizes mainly to the ER and to the Golgi apparatus [Rao et al., 
2007]. CERT orthologs are found in both invertebrates and vertebrates, but are 
absent in prokaryotes, unicellular eukaryotes, and plants [Hanada et al., 2009].  
 
The FFAT motif is required for the interaction of human CERT with human 
VAP-A protein in human (HeLa-S3) and CHO-K1 cultured cells [Kawano et al., 
2006]. The 230-aa START domain at the carboxyl-terminal of the protein is 
required for removing the ceramide molecules from the membranes and 
delivering them to other membranes (Fig. 4) [Ponting et al., 1999; Hanada et al., 
2003; Kumagai et al., 2005]. 
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SR motif phosphorylation is fundamental to regulate the localization of CERT 
to the ER, Golgi apparatus, and nucleus/cytoplasm. When the SR motif is 
hyperphosphorylated CERT is distributed to the nucleus/cytoplasm, because the 
SR motif phosphorylation induces an inhibitory interaction between START 
domain and PH domain [Kumagai et al., 2007]. Consequently, the PH domain 
cannot bind PI4P on the Golgi, the START domain cannot transfer the 
ceramide, and also the FFAT domain is unable to bind VAPs on the ER. When 
SR motif is dephosphorylated. The PH, START, and FFAT domains can fulfill 
their function, thus CERT can translocate to the Golgi apparatus or ER. In this 
context the Ceramide can be transferred from the ER to the Golgi complex 
[Kumagai et al., 2007].  
 
DCERT null mutant Drosophila strains present phenotypes such as decreased 
lifespan, increased susceptibility to oxidative stress of the plasma membranes, 
and decreased levels in Ceramide phosphoethanolamine (CPE) [Rao et al., 








Figure 4. Diagram showing the VAPB interacting partners that are implicated in lipid 
metabolism.  This figure illustrate PI4P being central among the activities of OSBP, Sac1, 
CERT, VAP, STT4k and Nir2. TGN= Trans-Golgi network. ER= Endoplasmic Reticulum. PM= 
Plasma Membrane. PtdIns=Phosphoinositide. PtdIns-4-P= Phosphoinositide-4-phosphate. 

















1.9 Aims of the project 
 
The molecular causes of VAPB-induced neurodegeneration in ALS type 8 are 
still poorly understood. As a number of proteins involved in lipid metabolism 
were identified as interacting partners of VAPs, it seems that VAPs play an 
important role in this pathway. It is tempting to hypothesize that the VAP-
mediated neurodegenerative process can be caused also by the disruption of 
some steps in lipid turnover. This hypothesis is reinforced by the fact that other 
neurodegenerative diseases are caused by alteration of this cellular process. In 
particular, the Sac1-DVAP interaction has been the starting point of this study. 
My PhD work has been developed as follows: 
 
1. Characterization of the interaction between Sac1 and DVAP 
2. Sub cellular localization of Sac1 and association of Sac1 and DVAP in vivo 
3. Functional characterization of the Sac1-DVAP interaction at the larval NMJ 





































       Chapter 2: 
2.1 Materials 
2.1.1 Drosophila melanogaster stocks 
Strain Source 
Canton S Bloomington Drosophila Stock Center 
Yw  Bloomington Drosophila Stock Center 
BG57-Gal4 




-Gal4 Bloomington Drosophila Stock Center 
Eyeless–Gal4 Bloomington Drosophila Stock Center 
ΦX-22A 
Bischof lab (Department of Cell Biology and 
Infection, Institut Pasteur, Paris, France) 
DVAP-P58S 
G. Pennetta (Centre for Integrative Phisiology, 
University of Edinburgh, UK)   
DVAP-T48I G. Pennetta (see above) 
DVAPRNAi Vienna Drosophila RNAi Center 
Sac1
133A
 G. Pennetta (see above) 
Sac1RNAi Vienna Drosophila RNAi Center 












2.1.2 General solutions and reagents: 
Reagent Source 
Agarose Melford Cat.9012-36-6 
Dithiothreitol (DTT)  Fluka Cat. 43817 
Ethylenediaminetetraacetic (EDTA) ICN Cat. 800683 
Sodium Chloride (NaCl) Fisher Scientific Cat. S/3105/63 
Normal Goat Serum Donor Herd 
(NGS) 




Protease inhibitor cocktail tablets 
(complete Mini, EDTA-free) 
Roche Cat. 11 836 170 001 
   Vectashield medium  Vector Laboratories Cat. 94010 
Picric Acid solution Sigma Cat. P6744 
Formaldehyde solution 37-41% Fisher Scientific Cat. F/1501/PB17 
Glacial Acetic Acid Fisher Scientific Cat. A/0400/PB17 
Paraformaldeide Sigma Cat. P6148 
Na pyrophosphate tetrabasic 
decahydrate, SigmaUltra, minimum 
99.0% 
Sigma Cat. S6422 
Na Fluoride Sigma Cat. S7920 
Na orthovanadate Sigma Cat. 450243 
10X Phosphate-buffered Saline 
(PBS) (stock solution) 
137 mM NaCl, 2.7 mM KCl, 10 mM 
Na2HPO4, 2mM KH2PO4 in MilliQH2O. 
Dilute to 1X PBS for working solution 
PBS-0.1% Triton (PBT) Dilute 10X PBS to 1X PBS and add 1% 
triton 
Luria Bertani (LB) broth granulated Melford Cat. GL1704 
LB agar granulated Melford Cat. GL1706 
10X Tris EDTA (TE) pH8.0 (stock 
solution) 
100mM Tris-Cl, 10mM EDTA (pH8.0) in 
total volume of 50 ml. 
1X Tris EDTA pH8.0 (working 
solution) 
Dilute the 10X TE to 1X TE with MilliQ 
H20  




2.2.1 Cloning procedure 
2.2.1.1 Polymerase Chain Reaction (PCR) 
 
In order to amplify DNA using the polymerase chain reaction (PCR) technique, 
the following reagents were mixed in a 0.5ml tube placed on ice: 26 μl of 
ddH2O, 5 μl of Pfu 10x reaction buffer, 5 μl of dNTP (10mM tock), 5 μl of 
forward primer (10mM tock), 5 μl of reverse primer (10mM tock), 3 μl of DNA 
template (300 ng), and 1 μl of Pfu polymerase enzyme. The total reaction 
volume was 50 μl. Then, a layer of equal volume of mineral oil was applied on 
top of the PCR mixture, to avoid evaporation. The tube was, then, placed in a 
thermo-cycler machine and the following cycling conditions were used;  
 
Step Time  Temperature (°C) Cycles 
DNA polymerase activation 2 min 95 1 
Denaturation 30 sec 95 
30 
 
Hybridization 50 sec 60 
Extension  2 min 68 
  
When the reaction was complete, the layer of mineral oil was discarded and the 
PCR mixture containing the DNA product was subjected to a phenol-
chloroform extraction procedure to remove proteins. 200 μl of 1XTE pH8.0 and 
200 μl of Phenol Chloroform-isoamyl alcohol mixture was added to the DNA 
mixture. After a centrifugation step at 12000xg for 5 minutes, the upper layer 
containing the DNA was placed into a clean microfuge tube. DNA was 
precipitated in 500 μl of 100% Ethanol and 20 μl 3M NaAc for 1h at -80°C or 
over night (O/N) at -20 °C. The next day the precipitated DNA was pelleted by 
centrifugation at 12000xg for 30 minutes. Excess ethanol was removed and the 
pellet was air-dried before being dissolved in 1XTE buffer pH 8.0, in 10-50 l.  
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Reagents and Solutions:  
Reagent Source 
Pfu polymerase enzyme and 
buffer 
Agilent (formerly Stratagene) Cat. 600670 
dNTP (10mM tock)  
Mineral oil Sigma Cat. 8042-47-5 
Phenol-Chloroform-isoamyl 
alcohol mixture 
Sigma Cat. 77617 
100% Ethanol AnalaR Normapur Cat. 20821.365 
Table 4. Reagents and Solutions for PCR 
 
2.2.1.2 Enzymatic restriction digestion 
 
Plasmid or PCR amplified DNA was subjected to a restriction endonuclease 
digestion reaction. In a total reaction volume of 40 μl, the following 
components were added: DNA re-suspended in 30 μl of 1XTE pH8.0, 4 μl of 
1XBSA, 4 μl of 10Xbuffer, 1 μl of enzyme 1 and 1 μl of enzyme 2. The 
digestion reaction was carried out at 37°C for 4 h. If the restriction enzymes 
buffers were not compatible, then two sequential individual digestion reactions 
were required. In this case the DNA was precipitated and re-suspended in 23 μl 
of 1XTE pH8.0, as the total volume of the digestion reaction was 30 μl. The 
reaction mixture was prepared as follows: DNA re-suspended in 23 μl of 1XTE 
pH8.0 3 μl of 1XBSA, 3 μl of 10Xbuffer, 1 μl of enzyme. In this case, the 
digestion reaction mixtures was incubated at 37°C for 2 h.  
 
When all the restriction digestion reactions were completed, DNA was 






Restriction enzyme Source 
Bam HI + buffer +10XBSA NEB Cat. R0136 
BglII + buffer +10XBSA NEB Cat. R0144 
EcoRI + buffer +10XBSA NEB Cat. R0101 
KpnI + buffer +10XBSA NEB Cat. R0142 
NotI + buffer +10XBSA NEB Cat. R0189 
SalI + buffer +10XBSA NEB Cat. R0138 
XbaI+ buffer +10XBSA NEB Cat. R0145 
Table 5. Reagents and Solutions of enzymatic restriction reaction 
 
2.2.1.3 Ligation reaction 
 
DNA fragments purified for cloning into an appropriate vector were digested 
with an appropriate restriction enzyme to ensure that both insert and vector had 
compatible ends that could allow the insertion of the DNA fragment in the 
vector. In order to optimize the ligation reaction outcome it was important to 
combine the two DNAs following a 1:3 insert: vector molar ratio. The amount 
of insert and the amount of the DNA molecules was roughly estimated by 
running 1 μl from each DNA sample on a 1% agarose gel. The reaction mixture 
had a final volume of 20 μl and it was prepared as follows: 16 μl of DNA insert, 
1 μl of DNA vector, 2 μl of 10X ligase buffer, 1 μl of T4 DNA Ligase. The 
ligation reaction was carried out at 16°C O/N. The next day the DNA constructs 
was ready for bacterial transformation.  
Reagents:  
Reagent Source 
T4 DNA Ligase + Buffer NEB Cat. M020T 
Table 6. Reagents and Solutions of ligation reaction 
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2.2.1.4 Bacterial transformation 
 
Plasmid DNA can be propagated in bacterial cells using a transformation 
procedure. Briefly, 100 μl of competent bacterial cells were thawed on ice and, 
after, they were incubated with 1.7 μl of β-Mercaptoethanol (β-ME) for 10 
minutes on ice. Super optimal broth (SOB) broth was preheated. 10 μl of the 
transforming DNA was added to the competent cells and the mixture was 
incubated on ice for 30 minutes. The transformation mixture was heat-pulsed at 
42°C for 45 seconds and immediately incubated for 2 minutes on ice, 
immediately after. 1 ml Super optimal catabolite repression (SOC) broth was 
added to the transformation mixture and the tube was incubated for 1 hour at 
37°C with shaking at 250 rpm. The transforming mixture was spread over LB 
agar plates with an appropriate antibiotic selection, depending on the plasmid 
used. The LB plates were left at 37°C over night. Bacterial colonies will only 
grow on LB agar plates if they are resistant to the antibiotic selection, which is 
conferred by an antibiotic resistance cassette that is present in the vector. The 
DNA from these colonies was extracted in order to check whether the desired 
construct has been obtained. This protocol was used to transform XL1-blue 




Table 7. Reagents and Solutions used for bacterial transformation 
 
2.2.1.5 Amplification and extraction of DNA using a boiling protocol 
 
Bacterial cells were prepared by inoculating 2 ml of LB broth containing 
appropriate antibiotic with a single bacterial colony in a bijoux tube. The 2ml-
bacterial cultures were incubated at 37°C O/N with vigorous shaking. The next 
day 1.5 ml from each inoculate was transferred to a 1.5ml microfuge tube, and 
the bacteria were pelleted by centrifugation at 12,000xg for 2 minutes at room 
temperature. The supernatant was discarded and the bacteria were re-suspended 
in 350 μl of cold STET buffer, the mixture was vortexed for few seconds and 
25l of a lysozyme solution  (10mg/ml in 10mM Tris-HCl, pH8.0) was added to 
the tube. The tubes were heat-shocked for 1 minutes at 95°C and immediately 
centrifuged at 12,000xg for 10 minutes. The bacterial debris pellet was picked 
up and trashed, whereas the supernatant was mixed with 40 μl of 2.5 M NaAc 
pH5.5 and 420 μl of isopropanol. The mixture was incubated for 5 minutes at 
room temperature, and then centrifuged at 12000xg for 10 minutes. The 
supernatant was discarded by aspiration and the DNA pellet was re-suspended 
Reagents and Solutions:  
Bacterial Strain Source 
XL1-blue supercompetent cells + 
β-ME 
Stratagene Cat. 20036 
SOB (1litre) Dissolve in 500 ml of ddH2O: 20 g of 
tryptone, 5 g of yeast extract, 0.5 g of 
NaCl, add MilliQ H2O to a final volume of 
1 liter and autoclave to sterilize. Add 10 ml 
of sterile 1 M MgSO4  and 10 ml of sterile 
1 M MgCl2 
 
SOC (1ml) 1ml of SOB medium, 20 μl of 1M glucose, 
10 μl of MgSO4. 5 μl of MgCl2 
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in 70% ethanol. The DNA was precipitated by centrifuging at 12000xg for 2 
minutes. After pouring off 70% ethanol was the DNA pellet was left to air dry 
before resuspending the pelleted DNA in 1XTE buffer pH8.0. The DNA 
obtained from this extraction was analysed by restriction endonuclease digestion 
to identify the clone of interest. 
 
Reagents and Solutions: 
Reagents Source 
Isopropyl alcohol Sigma Cat. I9030 
Lysozyme, from chicken egg 
white 
Sigma Cat. L6876 
STET buffer  10mM Tris-Cl (pH8.0), 0.1M NaCl, 1mM 
EDTA (pH8.0), 5%(v/v) Triton X-100 
Table 8. Reagents and Solutions of amplification and extraction of DNA by boiling 
miniprep 
 
2.2.1.6 Large scale preparation of DNA by alkaline lysis 
 
200 μl from the remaining bacterial culture corresponding to the right DNA 
samples were inoculated in 150 ml of LB broth containing the appropriate 
antibiotic selection. The culture was grown in a shaking incubator 12-16 hours 
at 37°C with vigorous shaking (200-250rpm). The DNA extraction was 
performed in the culture using the Qiagen Maxiprep kit (Qiagen) according to 
the manufacturer’s instructions. 300 μl of 1XTE buffer pH8.0 were used to re-
suspend the final DNA pellet. The DNA obtained from this extraction was 
analysed by restriction endonuclease digestion to double-check that the cDNA 
has been cloned properly in the vector. Finally, the clone DNA was direct-







Ampicillin Sigma Cat. A-9518 
Kanamycin Sigma Cat. K-4000 
Plasmid Maxi kit. Qiagen Cat. 12163 
Table 9. Reagents and Solutions of clean preparation of DNA by alkaline maxi prep 
 
2.2.2 Generation of UAS-FLAG-Sac1 transgenic flies: 
2.2.2.1 pUASTattb-FLAG-Sac1 cloning strategy: 
 
To generate a construct encoding D. melanogaster Sac1 protein having a 
FLAG-tag at the N-terminus we amplified 1.7 kb D. melanogaster Sac1 cDNA 
by PCR from GH08349 clone. BamHI and SalI restriction sites were 
incorporated into the primers to generate restriction sites at the 5’ and 3’ ends of 
the cDNA, respectively. Sac1 cDNA and pCMV-Tag2b (Clontech) (see 
Appendix 1, Fig. 26) were both cut with BamHI and SalI ligated to produce 
pCMV-Tag2b-Sac1. The sequences of the two primers were the following ones: 
 
BamHI-Sac1-F 5’ TATGGGATCCGAAATCATGGACAGCAGG 3’ 
SalI-Sac1-R 5’ CCGCGTCGACTAGCTGCAGAGGTAGTTC 3’ 
Restriction sites underlined. 
 
The pUASTattB-FLAG-Sac1 was generated by cloning FLAG-Sac1 into pUAST 
attB (obtained from A. Jarman, University of Edinburgh, U.K.) (see Appendix 
1, Fig. 29) by using BglII and XbaI restriction sites. The pUAST attB-Flag-Sac1 
construct was injected in ΦX-22A flies (y w M{eGFP.vas-int.Dm}ZH-2A; 
M{RFP.attP}ZH-22A; +; +) (Bischof et al., 2007, obtained from A. Jarman, 
University of Edinburgh, U.K.). 
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2.2.2.2 pUAST-FLAG-Sac1 cloning strategy: 
 
The pUAST-FLAG-Sac1 was generated by cloning FLAG-Sac1 into pUAST (see 
Appendix 1, Fig. 30) by using NotI and KpnI restriction sites.  
 
2.2.2.3 Injection Protocol 
 
Phi-C31 integrase system 
The transgenesis performed through Phi-C31 integrase system allows the 
integration of the heterologous DNA at precise intergenic sites within the fly 
genome [Bischof et al., 2007]. Thus, several fly strains have been developed 
containing several landing sites on the four chromosomes besides attP sites and 
Phi-C31 integrase gene [Bischof et al., 2007]. ΦX-22A flies having a landing 
site on the 2
nd
 chromosome were used in this case. Transgenic flies were 
generated in our lab by using the following basic injection protocol from 
Spradling and Rubin [1982]. Briefly, ΦX-22A flies were amplified and placed 
in an egg laying chamber on grape juice plate with yeast paste. Eggs were 
collected every 30 minutes to be injected using the FemtoJet/InjectMan NI2 
system, according to the manufacturer’s instructions (Eppendorf). Embryos 
were collected from the grape juice plate in a mesh basket using a fine brush 
and distilled water. Removal of the chorion (dechorionation) from embryos is 
required before injection to avoid needle breakage. This was performed by 
washing the embryos in 50% bleach solution for 3 minutes with continual 
agitation. The bleach solution was removed by using ddH2O. The 
dechorionated embryos were placed on a square piece of grape juice agar, and 
one edge of the piece of agar and the micropile used to orient and align the 
embryos. Embryos were transferred to a coverslip covered with a double-sided 
3M Scotch tape strip. The coverslip with embryos was placed on a microscope 
slide and the embryos were left to dry up in a chamber containing silica gel for 
1-3 minutes. The drying timed depended on the room humidity. A drop of 
 65 
halocarbon oil 700 (Sigma) was added to cover the embryos to prevent them 
from drying. DNA was loaded into the injection needle (3l of DNA, 500-600 
ng/μl concentration). DNA was injected into the posterior end of the embryo. It 
was important that the embryos were injected before the cellularization in order 
to optimize the injection efficiency. Injected embryos were kept in humid 
chambers overnight. The larvae that survived injection were placed in vial of 
standard fly food mixed with yeast paste. Adult flies were crossed to yw
 
 fruit 
flies. The transformant flies were identified among the off- spring by the 
presence of a light-orange eye colour. Stocks were established for each 
individual line identified.  
 
2.2.3 Immunocytochemistry: 
2.2.3.2  MYC- DVAP cloning strategy: 
 
To generate a construct encoding D. melanogaster VAPB (DVAP) protein 
having a Myc-tag at the N-terminus we amplified 810 bp DVAP cDNA by PCR. 
EcoRI and NotI restriction sites were added at the 5’ and 3’ of the cDNA 
respectively, using the following oligonucleotide primers:   
                                              
EcoRI-DVAP-F 5’GCCAGCGAATTCCCACAATGAGCAAATCAC 3’  
NotI- DVAP-R 5’ATAGCTGCGGCCGCTCAGAGAAAGAATTTG 3’ 
Restriction sites underlined 
 
DVAP cDNA and pCMV-Myc (Clontech) (see Appendix1, Fig. 27) were 
digested with EcoRI and NotI restriction endonuclease enzymes and ligated 




2.3.3 COS-7 cell transfection and staining: 
 
COS-7 cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM) 
containing 10% of fetal bovine serum (FBS), 1% penicillin/streptomycin, and 
1% glutamine. COS-7 cells were plated on BioCoatTM Poly-L-Lysine Coated 
Glass Coverslips of 12mm (BD Biosciences). Cells were transfected by 
Liposome transfection using FuGENE Transfection Reagent according to the 
manufacturer’s instructions. COS-7 were incubated for 24 h before being fixed 
in 4% paraformaldehyde for 20 minutes.  
 
For immunohistochemistry, cells were blocked in 0.1% Triton PBS (PBT) 
containing 10% normal goat serum (NGS) and, afterwards, stained with 1
st
 
antibody (αMyc rabbit polyclonal 1:200, and αFlag mouse monoclonal 1:200) in 
PBT containing 5% NGS for 2h. COS-7 cells were washed 8x15 minutes with 
PBT and they were incubated with 2
nd
 Ab (Fluorescein isothiocyanate (FITC) 
αRabbit 1:500, and Cy3 αMouse 1:500) in PBT containing 5% NGS for 2h at 
room temperature afterwards. The cells were washed 8x15 minutes with PBT. 
The coverslips were mounted on microscope ground color frosted slides (VWR) 














Reagents and solutions: 
Reagent Source 
DMEM Gibco Cat. 21063 
Fugene 6 transfection 
reagent 
Roche Cat. 11 815 091 001 
Triton X-100 Sigma Cat. T9284 
rabbit αMyc polyclonal Sigma Cat. C3956 
mouse monoclonal 
αFlag  
Sigma Cat. F3165 
FITC Goat α-Rabbit 
IgG 
Jackson ImmunoResearch Cat. 111-095-003 
Cy3 Goat α-Mouse IgG Jackson ImmunoResearch Cat. 115-165-146 
Table 10. Reagents used in Immunocitochemestry 
 
2.2.4 Co-immunoprecipitation (CoIP): 
2.2.4.1 Cloning strategy: 
Myc-Sac1 
In order to generate a construct encoding D. melanogaster Sac1 protein having a 
Myc-tag at the N-terminus end, we amplified 1.7 kb D. melanogaster Sac1 
cDNA by PCR from GH08349 clone. SalI and KpnI restriction sites were added 
at the 5’ and 3’ of the cDNA, respectively, using the following oligonucleotide 
primers:  
 
SalI-Sac1-F5’ GATTGTCGACAATCATGGACAGCAGGG 3’ 
KpnI-Sac1-R 5’ GATTGGTACCTGCTAGACGACACTAAC 3’ 
Restriction sites underlined 
Sac1 cDNA and pCMV-Myc (Clontech) were digested with SalI and KpnI 




To generate a construct encoding D. melanogaster VAPB (DVAP) protein 
having a Flag-tag at the N-terminus we amplified 810 bp DVAP cDNA by PCR 
from their pBluescript vectors (G.Pennetta). EcoRI and SalI restriction sites 
were added at the 5’ and 3’ of the cDNA respectively, using the following 
oligonucleotide primers: 
 
EcoRI-DVAP-F5’ ATGCGAATTCGAACAACACCAGGAGCAG 3’ 
SalI-DVAP-R5’ GAGTGTCGACCGTTTATGGCATTCAGAG 3’ 
Restriction sites underlined 
pCMV-Tag2 is a vector that contains a Flag-tag coding region upstream the 
multiple cloning site. DVAP cDNA and pCMV-Tag2 (Sigma) were digested 
with EcoRI and SalI restriction endonucleases and ligated together to produce 
pCMV-Tag2- DVAP.  
 
Flag-DVAP-P58S  
Site-directed mutagenesis on DVAP cDNA was performed using QuikChange 
Site Directed Mutagenesis Kit (Agilent/Stratagene), according to the 
manufacturer’s instructions [Chai et al., 2008]. The same cloning strategy used 
to generate Flag-DVAP was used to generate a construct encoding D. 
melanogaster VAPB-P58S (DVAP-P58S) protein having a Flag-tag at the N-
terminus.  
 
 2.2.4.2 COS-7 cell transfection and CoIP: 
 
COS-7 cells were transfected with plasmid DNA as described previously. Two 
days after transfection, confluent cells were trypsinized and resuspended in 
DMEM containing the FBS. The cells were centrifuged at 1000xg for 5 
minutes, the supernatant was discarded and the cells were re-suspended in PBS. 
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The cells were centrifuged again as before, the supernatant was discarded and 
cells were re-suspended in fresh lysis buffer. Cell lysis was performed by 
incubating cells in 1% digitonin Hepes Buffer [Kawano et al., 2006] for 45 
minutes on ice. After the cells were solubilized, an aliquot was removed to use 
as an input sample. The input sample was kept until loading in 5% β-ME 
Laemmli sample buffer. The remaining cell lysate was centrifuged at 12000xg 
for 20 min at 4°C. Pierce Spin Columns were placed in microcentrifuge 
collection tubes. The supernatant was incubated with the slurry Pierce anti-c-
Myc agarose resin (Pierce-c-myc IP/CO-IP kit) in Pierce Spin Columns O/N at 
4°C under constant rotation. After incubation, the samples were centrifuged at 
2000 rpm? for 5 min in order to separate the beads from the supernatant. The 
beads remaining in the column, were washed three times with 0.1% digitonin 
Lysis buffer. 25 μl 2X Non-Reducing Sample Buffer, prepared from the 5X 
Sample Buffer from the kit, was added to the beads. The column/collection 
assembly was heated at 95°C for 5 min, pulse centrifuged for 10 s immediately 
after. β-ME was added at a concentration of 4% to the eluted sample in order to 
prepare the sample for reducing Sodium-dodecyl-sulfate-polyacrylamide gel 















Reagents and solutions: 
Reagent Source 
Digitonin Sigma Cat. D141 
Hepes Sigma Cat. H4034 
Laemmli sample buffer Biorad Cat. 161-0737 
β-ME Sigma Cat. M3148 
Profound c-Myc Tag 
IP/Co-IP application set 
Thermal Scientific Cat. 23622 
1X Hepes Lysis Buffer 
(10ml) 
5 ml MilliQH2O, 5 ml 2X Hepes Lysis Buffer, 20 
μl 0.5M DTT, 100 μl 100mM PMSF, 1 tablet 
protease inhibitors 
2X Hepes Lysis Buffer 
(Lysis Buffer)  
 
50 mM Hepes-NaOH, pH7.4, 1mM EDTA, 50 mM 
NaCl, 5 mM Na pyrophosphate, 50 mM Na 
Fluoride, 1 mM Na orthovanadate 
Table 11. Reagent and solutions required to perform the Co-IP 
 
2.2.4.3 Western Blot analysis: 
 
The samples obtained by CoIP procedure were analysed by Western Blot. A 
12% SDS-PAGE was prepared and the protein samples were loaded together 
with a molecular weight marker. Samples were resolved by gel electrophoresis 
at 100 volts for 90 min. The proteins were transferred from the gel onto 
Hybond-P PVDF membranes (Amersham Biosciences), in order to make them 
accessible to antibodies for detection. This transferring step was performed by 
applying an electric field of 120 V for 2 h to the proteins. Later, the membranes, 
having the proteins on their surface, were incubated in blocking solution over 
night at 4°C. This solution was made by dissolving ECL Advance Blocking 
Agent at a 2% in Tris buffered solution with 0.1% Tween (TBS-T). The 
following day, the membranes were incubated with the primary antibodies 
diluted in blocking solution for 2 hours at room temperature with gentle 
shaking. For VAP detection, guinea pig anti-DVAP (GP33, 1:40,000) antibody 
was added to one membrane in order to detect Flag-DVAP fusion protein, and 
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rabbit anti-c-Myc (1:10,000) to the other membrane to detect Myc-Sac1 tagged 
protein. Then, the excess of primary antibody was removed by washing the 
membranes vigorously with TBS-T for 2 hours changing the buffer every 15 
minutes. Membranes were incubated with secondary antibodies at room 
temperature for 2 hours under gentle agitation. Goat anti guinea pig HRP 
(1:60,000) was added to bind anti-DVAP, and Ab Goat anti rabbit HRP 
(1:30,000) was used to bind rabbit anti-c-Myc. Vigorous washes with TBST 
were performed as. Enhanced chemo-luminescence (ECL) Advance Western 
Blotting Detection Kit was used to detect signals from the secondary antibodies 
according to the manufacturer’s instructions. The excess of detection solution 
was drained off from the membrane by using a tissue, and each membrane was 
wrapped in SaranWrap. The wrapped blots are placed in an X ray film cassette. 
An autoradiography film is placed on the protein side of the wrapped blot. The 
membrane was exposed to autoradiography film (Hyperfilm
TM
ECL) for 60 
seconds. The film was then submerged in developer for 30-60 seconds, rinsed in 




2% ECL Advance Blocking 
Agent  
Amersham Bioscience Cat.  
SeeBlue Plus2 Pre-stained 
Standard 
Invitrogen Cat. LC5925 
EZblue gel staining reagent Sigma Cat. G1041 
Tween-20 Sigma Cat. P5927 
HRP Goat anti-GP IgG Jackson Immunoresearch 
HRP Goat anti-Rabbit IgG Jackson Immunoresearch 
Table 12. Reagents used to perform the Western Blot analysis 
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2.2.5 Generation of anti-Sac1 antibodies: 
          
In order to generate an antibody against Drosophila Sac1 protein, a Drosophila 
Sac1 antigen must be produced. The steps regarding the generation of an anti-
Sac1 antibody encompass: 
1. The generation of a cDNA fragment encoding Sac1 protein or Sac1 protein 
deletion derivative.  
2. The production of the antigen that has to be injected into the animal where 
the antibody has to be produced. 
 
2.2.5.1 Generation of the sequence encoding the antigen  
          
In order to generate a cDNA sequence encoding the antigen the general cloning 
procedure has been followed as previously described in this section (paragraph 
2.2.1). In order to clone Sac1 cDNA full-length and Sac1 cDNA deletion 
derivatives in the proper vector specific cloning strategies have been followed, 
as it is described below.  
  
 (His)6-Sac1 
To generate a construct encoding Sac1 fusion protein having a His-tag at the N-
terminus we amplified 1.7kb Sac1 cDNA by PCR from GH08349 clone. BamHI 
and SalI restriction site were added at the 5’ and 3’ of the cDNA respectively. 
pET28a is a vector that contains the His-tag coding region. Sac1 cDNA and 
pET28a (Novagen) (see Appendix 1) were digested with BamHI and SalI 
restriction endonuclease enzymes and ligated together to produce pET28a-Sac1. 
The sequences of the two primers used in this cloning procedure are: 
BamHI-Sac1-F 5’TATGGGATCCGAAATCATGGACAGCAGG 3’ 
SalI-Sac1-R 5’TTACGTCGACTCATGGGTCTCGAAAGGA 3’ 
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Restriction sites underlined. 
(His)6-Sac1 Δ483-594 
To generate a construct encoding the Sac1 deletion derivative having a His-tag 
at the N-terminus we amplified 1.448 kb Sac1 cDNA by PCR from GH08349 
clone. BamHI and SalI restriction site were added at the 5’ and 3’ of the cDNA 
respectively. Sac1 cDNA and pET28a (Novagen) were digested with BamHI 
and SalI restriction endonuclease enzymes and ligated together to produce 







To generate a construct encoding the Sac1Δ354-594 deletion derivative having 
a His-tag at the N-terminus we amplified 1.061kb Sac1 cDNA by PCR from 
GH08349 clone. BamHI and SalI restriction site were added at the 5’ and 3’ of 
the cDNA, respectively. Sac1 cDNA and pET28a (Novagen) were both digested 
with BamHI and SalI restriction endonuclease enzymes and ligated together to 
produce pET28a-Sac1Δ354-594. The sequences of the two primers used in this 







To generate a construct encoding Sac1Δ1-309 deletion derivative having a His-
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tag at the N-terminus we amplified 858 bp Sac1 fragment cDNA by PCR from 
GH08349 clone. BamHI and SalI restriction site were added at the 5’ and 3’ of 
the cDNA respectively. Sac1 cDNA and pET28a (Novagen) were digested with 
BamHI and SalI restriction endonuclease enzymes and ligated together to 
produce pET28a-Sac1Δ1-309. The sequences of the two primers used in this 
cloning procedure are: 
BamHI-Sac1Δ1-309-F 5’GCATATGGATCCGATCACAAAGGTGCCGAA 3’ 
SalI-Sac1Δ1-309-R 5’ TTACGTCGACTCATGGGTCTCGAAAGGA 3’ 
 
(His)6-Sac1Δ1-267 
To generate a construct encoding Sac1Δ1-267 deletion derivative having a His-
tag at the N-terminus we amplified 984 bp Sac1 fragment cDNA by PCR from 
GH08349 clone. BamHI and SalI restriction site were added at the 5’ and 3’ of 
the cDNA respectively. Sac1 cDNA and pET28a (Novagen) were digested with 
BamHI and SalI restriction endonuclease enzymes and ligated together to 
produce pET28a-Sac1Δ1-267. The sequences of the two primers used in this 
cloning procedure are: 
BamHI-Sac1Δ1-309-F 5’GCATATGGATCCCTGCCCAATTTGCGCTAT 3’ 
SalI-Sac1Δ1-309-R 5’ TTACGTCGACTCATGGGTCTCGAAAGGA 3’ 
 
2.2.5.2 Antigen production 
 
When the clones have been generated, the antigen should be produced and 
purified from the other proteins of the bacterial host cell. The purified antigen 
has been quantified in order to inject the required amount of antigen into the 
host animal. 
2.2.5.2.1 Setting up the bacterial culture: 
BL21(DE3) competent cells were transformed as described before in this 
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chapter. Bacterial cells can be induced to generate the target protein of interest. 
Briefly, a single colony was inoculated in 5 ml of LB broth containing the 
appropriate antibiotic. This starter bacterial culture was incubated at 37 °C with 
vigorous shaking (220-250 rpm) until it reached 0.5 OD600. Then, the bacterial 
culture was stored at 4°C until the next morning. The next day, the bacteria 
from 1 ml of starter culture were pelleted down at 5000 x g for 30 seconds in 
micro-centrifuge, and re-suspended in 1 ml of LB broth with the appropriate 
antibiotic freshly added. This 1ml-culture was inoculated in 50 ml of LB broth 
plus the appropriate antibiotic, and, the 50-ml-culture was made in duplicate. 
Incubation of the two bacterial cultures was carry out at 37°C under 220-250 
rpm shaking speed until the OD600 between 0.6 and 1.0 was reached.  
 
2.2.5.2.2 Synthesis of the heterologous protein: 
1ml samples were removed from each bacterial culture and they were used as 
un-induced samples. Un-induced bacterial controls were spun down by 
centrifugation at 5000 x g for 5 minutes. At this point the bacteria were ready to 
be treated in order to induce the expression of (His)6-tag fusion protein. For this, 
500 μl of Isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to each 
bacterial culture in order to obtain a final IPTG concentration of 1mM and the 
bacterial cultures were incubated for 2 h with vigorous shaking at 37°C. Then, 
the two bacterial cultures are placed on ice for 5 minutes and the bacteria were 
harvested by centrifuging them for 5 minutes at 5000 x g at 4°C. The 
supernatant was discarded and the pellet was stored at -80°C.  
 
2.2.5.2.3 Protein extraction from BL21(DE3) bacteria 
Protein extraction was carried out on bacterial pellets from cultures treated with 
IPTG and from the control bacterial cultures, untreated with IPTG. BugBuster 
(Novagen) protein extraction reagent was added to each bacterial pellet: 5 ml of 
the reagent were added per gram of wet pellet weight (=1 volume). 
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Additionally, 1 μl of benzonase nuclease per ml BugBuster protein extraction 
reagent was added to the mixture. The cell suspension was incubated for 15 
minutes with gently shaking at room temperature (RT). Afterwards, the 
insoluble debris were removed by centrifuging the bacteria for 20 minutes at a 
16000 x g speed at 4°C. The supernatant was transferred to a fresh tube and 2x 
Laemmli sample buffer, which was previously equilibrated with β-
mercaptoethanol, was added to the supernatant sample at a 1:1 ratio, and it was 
stored at -20°C until loading. The debris pellet was thoroughly re-suspended in 
1 volume of Bugbuster protein extraction reagent and in 1KU of rLysozyme 
solution per ml of Bugbuster protein extraction reagent. Next, the suspension 
was mixed thoroughly, and incubated at RT for 5 minutes. The Bugbuster 
protein extraction reagent was diluted 1:10 using deionized water, and 6 
volumes of the diluted reagent were added to the mixture. The suspension was 
vortexed for 1 minute and then centrifuged for 15 minutes at 5000 x g at 4°C. 
The supernatant was discarded, and the previous two steps, re-suspension and 
centrifugation, were repeated three times, using half the volume of the original 
bacterial culture (25 ml) of 1:10 of Bugbuster protein extraction reagent to re-
suspend the pellet. The last centrifugation step was carried out at 16000 x g. The 
supernatant was discarded, and the pellet was re-suspended in 1.5 ml of 
1%SDS. The pellet was resuspended in 1%SDS for 2-3 minutes. 20 μl was 
mixed with an equal volume of 5% β-ME Laemmli sample buffer. The samples 
were kept at -20°C until use.  
 
2.2.5.2.4 Protein Purification 
The pellet from the previous centrifugation was re-suspended in 2.5ml 8M Urea, 
1X Binding buffer and incubated in ice for 1h. The protein suspension was 
centrifuged for 30 min. at 16000 xg at 4°C. The elution, the wash, and the 
charge buffers together with the columns were prepared for the protein 
purification step.  Once the buffers were arranged 2-3 ml of sterile ddH20 were 
added to the column. The His-bind resin was gently mixed by inversion to re-
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suspend the resin in the storage buffer and 2ml of the suspension were 
transferred into the column where it passed through by gravity flow. When the 
storage buffer level went down, the following sequence of washes was used: 
- 3 volumes of sterile ddH20 (3ml) 
- 5 volumes of Charge Buffer (5ml) 
- 3 volumes of Binding Buffer (3ml) 
The protein sample was applied to the column and treated by adding the 
following reagents: 10 volumes of 1X Binding Buffer (10ml), 2 volumes of 1X 
Wash Buffer, 6 volumes of 1X Elution Buffer. Each ml of 1X Elution buffer 
exiting the column was saved separately. Each ml corresponds to one elution 
fraction. All the elution fractions were loaded on a 8% acrylamide gel for 
Western Blot analysis of the fraction to determine where the majority of the 
eluted protein was concentrated. The buffers and the (His)6-bind resin are 
included in (His)6-Bind Purification Kit (Novagen Cat. 70239-3). 
 
2.2.5.2.5 Protein Quantification 
The elution fractions containing the majority of the recombinant protein were 
pooled together and 20μl were loaded for comparison to known BSA dilutions 
(0.01 μg, 0.1 μg, 1 μg, 5 μg, 10 μg). As the Sac1 fragment appeared to have a 
concentration close to 1 μg, we made another more precise, quantification 
comparing our protein to the following BSA dilutions: 0.5 μg, 1 μg, 1.5 μg, and 
2 μg. The success of protein extractions from inclusion bodies was tested by 
loading the protein samples on 8% acrylamide gel. Simultaneously, a protein 
ladder was loaded on the acrylamide gel together with the samples in order to 
recognize the Sac1 protein fragment by its size. The acrylamide gel was washed 
in ddH20 in order to remove the SDS in excess. Next, the gel was incubated in 
EZ Blue gel staining reagent (Sigma) in order to dye all the proteins on the gel 
for 45 min. at RT. Excess staining reagent was removed by incubating the gel in 
ddH20 over night at RT. The next morning the gel was treated with a de-
staining solution (20% methanol and 3% glycerol).  
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         Reagents 
Reagent Source 
Sodium dodecyl sulphate (SDS) Sigma Cat. L4509 
Benzonase Nuclease Novagen Cat. 70664-3 
BL21 (DE3) Competent cells + β-
ME 
Stratagene Cat. 200131 
BSA fatty acid free low endotoxin  Sigma Cat. A8806 
Bugbuster Reagent Novagen Cat.70584 
EZ blue gel staining reagent Sigma Cat. G1041 
IPTG Sigma Cat. I6758 
rLysozyme
TM
 solution  Novagen Cat. 71110-3 
Table 13. Reagents used in the process to generate the anti-Sac1 antibody 
 
2.2.6 Immunohistochemistry:  
2.2.6.1 NMJ staining and larval muscles staining 
 
Fly crosses were set up for 20-24 h at room temperature before being transferred 
to a 30°C water-bath. Third instar larvae of the required genotype were 
dissected in 1XPBS to fillet the larvae. The dissected tissues, usually from 8 
animals per set, were fixed in Bouin’s fixative for either 5 min or 10 min, 
according to the antibody that was used. The fixation reaction was stopped by 
rinsing the tissues with PBT. The fixed preparations were blocked in PBT with 
10% NGS for 2h at room temperature under continuous rotation. The 
preparations were incubated over night with primary antibody at the required 
concentration in PBT containing 5% NGS, under constant rotation at 4°C. The 
next morning the tissues were washed 8x15 minutes with PBT, before 
incubation with 2
nd
 antibody in PBT with 5% NGS for 2 hours at RT under 
gently shaking. Excess secondary antibody was removed by washing the 
preparations in PBT 8 times, changing the solution every 15 minutes. Tissues 
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were mounted on microscope ground colour frosted slides (VWR) using 
Vectashield medium. An Axiovert Zeiss microscope was used to visualize the 
larval neuromuscular junctions.  
 
2.2.6.2 Larval brains, larval salivary glands, and larval eye imaginal discs 
staining 
 
The third instar larvae of the required genotype were dissected in 1XPBS. The 
dissected tissues, usually from 20 animals per set, were fixed in 4% 
paraformaldehyde fixative for 10-20 min, accordingly to the antibody that was 
used. The fixation reaction was stopped by rinsing the tissues with PBT. The 
preparations were blocked in PBT with 10% NGS for 2h at room temperature 
under continuous rotation. Preparations were incubated over night with primary 
antibody at the required concentration in PBT containing 5% NGS, and they 
were kept under constant rotation at 4°C. The next morning the tissues were 
washed 8x15 min. with PBT before being incubated with 2
nd
 antibody in PBT 
with 5% NGS for 2 hours at RT under gently shaking. Excess of secondary 
antibody was removed by washing the preparations in PBT 8 times, changing 
the solution every 15 minutes. Tissues were mounted on microscope ground 
colour frosted slides (VWR) in Vectashield medium. An Axiovert Zeiss 












Reagents and Solutions: 
Solution Recipe or Source 
4% paraformaldehyde (50 
ml) 
50 ml PBS, 2g paraformaldehyde 
Bouin’s fixative 15ml saturated picric acid, 5ml 37% 




Jackson ImmunoResearch Cat. 323-005-021 
Guinea Pig α-DVAP (GP33)  G. Pennetta 
Mouse monoclonal α-KDEL  Stressgen Bioreagents Cat. SPA-827 
Rabbit α-Sac1  G. Pennetta 
Mouse α-DLG DSHB  
Mouse α-HTs1B1 DSHB  
α-Boca (Culi’s group) 
α-dGM130 Abcam Cat. Ab30637 
α-Fustch DSHB 
α-dCSP2 DSHB 
Mouse α-Adducin DSHB 
Rabbit α- βspectrin Cat.  
Cy3 Goat α-guinea pig IgG Jackson ImmunoResearch Cat. 106-165-003 












Primary Antibody dilutions: 
Antibody  Concentration 




Mouse α-Adducin 1:50 
Rabbit α- βspectrin 1:500 
Mouse α-DLG 1:50 

















2.2.7 Adult Drosophila Eye paraffin sections: 
Adult fruit flies of the appropriate genotype were dissected to leave just the 
head attached to the abdomen. The proboscis was removed from the head, and 
the heads together with abdomen were incubated in fixative solution O/N at RT 
under gently shaking. The next day, fixed heads were moved from the fixative 
solution to an 80% ethanol solution and they were stored at 4°C. Later, the flies 
were placed in the “Martin Heisenberg fly collar” whilst they were kept in 80% 
ethanol solution. Fly heads were dehydrated as follows: incubation in 95% 
ethanol solution for 5 minutes, incubation in 100% ethanol for 10 minutes. 
Following the dehydration step, the heads were incubated in a solution of 1:1 
100%Ethanol/Xylene for 5 minutes. Heads were incubated in a 1:1 
xylene/paraffin solution. The heads were left in 100% paraffin O/N at 65°C. 
The next day, liquid paraffin was poured into the metal boats and the fly collars 
with heads were transferred to the metal boats. Once the paraffin block was 
made the heads were ready for microtome sectioning. The paraffin sections 
were slice to obtain a thickness of 4μm. The slices were transferred to 
‘Superfrost
+
 slides’. The samples underwent Haematoxylin + Eosin staining. 







































Chapter 3: Sac1 physically associates with DVAP 
3.1 Introduction 
 
The relationship between neurodegeneration and the mutations T46I and P56S 
in the MSP domain of hVAPB has been proved [Chai et al., 2008; Chen et al., 
2010]. However, the exact molecular mechanism underlying the ALS8-
mediated neurodegeneration is still unclear. To address this issue we decided to 
look at the interacting partners of the Drosophila orthologue of hVAPB protein 
DVAP-33A or DVAP. Thus, a yeast two-hybrid screen performed by Dr. K. 
Parry, aimed at identifying interacting partners of DVAP identified a direct 
interaction between Sac1 phosphatase and DVAP. This interaction has been 
identified already in yeast during a genome-wide yeast two-hybrid screen by 
Giot et al., [2003].  
 
The interest in the analysis of this protein-protein interaction in the study of the 
molecular mechanism underlying ALS 8 comes from a number of reasons. First, 
a SAC3, also known as FIG4, a protein belonging to the SAC protein family, 
was found mutated in some ALS cases. SAC3 is a PIP phosphatase which 
dephosphorylates PI3P specie [Chow et al., 2007]. Second, other 
neurodegenerative diseases are caused by mutations in gene encoding enzymes 
involved in PIP metabolism.  Mutations in SAC3 were identified also in 
Charcot-Marie-Tooth disorder sufferers [Chow et al., 2007]. Charcot-Marie-
Tooth disease is a MND. Also same cases of Alzheimer disease were associated 
to mutations in a PIP phosphatase, synaptojanin 1 [Voronov et al., 2008]. This 
phosphatase is mainly expressed in neurons where it has PI(4,5)P2 as substrate 
[Di Paolo and De Camilli, 2006; Gong and De Camilli, 2006]. Lastly, evidence 
of the implication of VAPB protein in regulating the activity of Sac1 was 
reported in yeast [Stefan et al., 2011]. All together these pieces of evidence 
suggest that the characterization of the interaction between dSac1 and DVAP 
could be used to determine the molecular cause of the VAPB-mediated ALS. 
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Thus, as a starting point, the dSac1-DVAP association has been confirmed in 
vitro.  
 
3.2 The interaction between DVAP and Sac1 is detected by co-
immunoprecipitation 
 
In order to confirm this interaction in vitro, the co-immunoprecipitation (Co-IP) 
assay was used. Firstly, two tagged proteins were generated: Myc-DVAP and 
Flag-Sac1. Myc-tag has been chosen as it is a small peptide (11 aa with a MW 
of 1.20 kDa, N-EQKLISEEDL-C) and it is hydrophilic. These two 
characteristics allow this tag to be placed outside the protein during the proteon 
folding. Therefore, myc-tag can affect marginally the tertiary structure of 
DVAP protein, and, thus, DVAP function. In addition, a myc-tagged DVAP 
fusion protein has been previously generated [Ratnaparkhi et al., 2008]. 
Similarly, the human orthologue of DVAP (hVAPB) has been fused to the myc 
peptide [Peretti et al., 2008; Suzuki et al., 2009; Kim et al., 2010], meaning that 
small tags can be attached to VAP proteins without significantly affecting their 
function.  In addition, the Myc-tag has been successfully used in 
immunoprecipitation assays [Kipriyanov et al., 1996]. Thus, DVAP was 
conjugated with a myc-tag and the beads crosslinked with an antibody against 
myc was used. N-terminal myc-DVAP fusion protein was generated (Fig. 5) by 
cloning DVAP cDNA in pCMV-Myc vector that includes a myc-encoding 
sequence upstream the MCS (see Appendix 1, Fig. 27).  
 
On the other hand, Sac1 protein was conjugated to a different protein tag (flag-
tag) (Fig. 5). The flag-tag is also a small (8 aa with a MW of 1.01 kDa, 
DYKDDDDK) [Hopp et al., 1988] and highly hydrophilic peptide [Terpe et al., 
2003]. N-terminal flag-Sac1 tagged protein was generated by cloning Sac1 
cDNA in pCMV-Tag2B vector, which contains a flag-tag-encoding sequence 
upstream the MCS (see Appendix 1, Fig. 26). In parallel, the possibility that the 
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ALS8-causative mutation P56S could affect the interaction between Sac1 and 
hVAPB was explored. To this end DVAP cDNA has been mutagenized in order 
to express a DVAP protein having the proline-58 that corresponds to the 
proline-56 in hVAPB, changed to a serine. Then, DVAP-P58S cDNA was 
cloned in pCMV-Myc vector in order to generate Myc-tagged DVAP-P58S 
fusion protein.  
 
Subsequently, COS-7 cells were used as an expression system and, thus, they 
were transfected as follows: pCMV-Tag2b-Sac1 together with pCMV-Myc-
DVAP, and pCMV-Tag2b-Sac1 together with pCMV-Myc-DVAP-P58S. In 
addition three single transfections with the three constructs (pCMV-Tag2b-Sac1 
alone, pCMV-Myc-DVAP alone, and pCMV-Myc-DVAP-P58S alone) were used 
as controls. In fact, flag-Sac1 fusion protein cannot precipitate with the beads in 
the absence of myc-DVAP. Then, the proteins were extracted from COS-7 cells 
by using a lysis buffer containing the mild detergent digitonin [Kawano et al., 
2006]. Whether a detergent is defined mild or not it depends on its ability to 
denature proteins. Anti-Myc beads were used to precipitate DVAP-Sac1 
complex and the DVAP-P58S-Sac1 complex. The presence of the fusion protein 
was tested on input, supernatant and pellet fractions from the COS-7 lysates. 
The input fraction represents the lysate before treatment with the beads 
crosslinked with the anti-myc antibody. The pellet fraction corresponds to the 
lysate treated with the beads. The supernatant represents the fraction of the 
lysate including all the proteins that were not bound by the beads.  An antibody 
against DVAP and an antibody against flag-tag were used to detect the fusion 
proteins by immunoblot. The antibody against flag-tag gave an unspecific signal 
for flag-Sac1 in the input fraction of all the lysates (data not shown). However, 
a specific signal was detected when supernatants and input fractions from all the 
COS-7 samples were incubated with the same antibody and the anti-DVAP 
antibody (data not shown). These results suggested the presence of a problem in 
the precipitation step of Flag-Sac1 fusion protein by using the beads conjugated 
with the anti-Myc antibody.  
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Figure 5. Flag-Sac1 and Myc-DVAP fusion proteins. This figure shows the two fusion 
proteins that have been generated in the first instance to perform a Co-IP in order to confirm the 
interaction between DVAP e Sac1. Flag-Sac1 is represented on the top of the figure, whereas 
myc-DVAP is reported at the bottom of the figure. The relevant domains are represented in each 
scheme of the protein. Look at the ‘Introduction section’ for further details about these domains. 
The protein schemes have been generated using DOG 1.0 software [Ren et al., 2009].  
 
To circumvent the problem described above, COS-7 cells were cotransfected 
with the following constructs: pCMV-Myc-Sac1 and pCMV-Tag2B-DVAP (Fig. 
6A-B). In the cell extracts expressing both Myc-tagged Sac1 and Flag-tagged 
DVAP, the presence of Myc-Sac1 and Flag-DVAP was tested, also in this case, 
in the three fractions (input, supernatant and pellet) from COS-7 lysates 
expressing Myc-Sac1 together with Flag-DVAP, Myc-Sac1 alone, and Flag-
DVAP alone (Fig. 6). In this case Myc-Sac1 and Flag-DVAP were detected by 
anti-Myc and anti-DVAP antibodies by Immunoblot. These results clearly show 
co-immunoprecipitation of Flag-tagged DVAP together with Myc-tagged Sac1 
(Fig. 6C). Instead, Flag-DVAP and Myc-Sac1 were not detected in the pellet 
fraction from lysates from COS-7 cells transfected with pCMV-Tag2B-DVAP 
(encoding Flag-DVAP) alone (Fig. 6C). In this case Flag-DVAP did not 
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immunoprecipitate with the beads, as this fusion protein could not bind the 
beads by itself. In addition, Flag-DVAP was not detected in the pellet fraction 
from COS-7 cells transfected with pCMV-Myc-Sac1 (encoding Myc-Sac1) 
alone. The results from this experiment indicate that Flag-DVAP binds to the 
beads through the interaction with Myc-Sac1. Thus, the coimmunoprecipitation 
of Flag-DVAP and Myc-Sac1 shows the interaction between these two proteins, 
although it does not prove a direct interaction. These data support the idea that 
Sac1 and DVAP interact. It was observed by yeast two-hybrid.  
 
3.3 The association between Sac1 and DVAP is not affected by ALS8 
mutations in DVAP 
 
A Flag-tagged protein for the mutant form of DVAP, DVAP-P58S, was also 
produced. The construct encoding Flag-DVAP-P58S was generated by cloning 
DVAP-P58S cDNA [Chai et al., 2008] in pCMV-Tag2B vector (see Appendix1, 
Fig. 26). Myc-tagged Sac1 and Flag-DVAP-P58S were co-expressed in COS-7 
cells. The analysis of the presence of the fusion proteins was carried out as 
described in the previous paragraph. The Immunoblot analysis clearly shows the 
presence of the two proteins in the pellet fraction of the lysates, indicating that 
the two fusion proteins co-immunoprecipitate (Fig. 6C). Also in this case single 
transfections with each one of the used constructs, pCMV-Tag2B-DVAP-P58S 
and pCMV-Myc-Sac1, have been performed. Coimmunoprecipitation of DVAP-
P58S and Myc-Sac1 was not observed in the pellet fractions of the lysates from 
the single transfected COS-7 cells (Fig. 6C). These data indicate that also the 
mutant form of DVAP (DVAP-P58S) interact with Sac1. Thus, the ALS 
causative mutation in DVAP does not disrupt the interaction between DVAP 










Figure 6. DVAP wt and DVAP-P58S and DVAP-T48I interact with with Sac1 by Co-IP. 
(A, B) represents the schemes of the Flag-Sac1 and Myc-DVAP fusion proteins with respect. 
The protein schemes have been generated using DOG 1.0 software [Ren et al., 2009]. 
Constructs encoding these two fusion proteins have been used during the first attempt of Co-IP. 
Either Flag-DVAP or Flag-DVAP-P58S and Myc-Sac1 fusion proteins were co-expressed in 
COS-7 cells. In addition, each construct was individually expressed in COS-7 cells and it was 
used as a control. Cell extracts were immunoprecipitated by using anti-Myc crosslinked with 
beads. Input (I), pellet (P), and supernatant (S) samples were analyzed by Western Blot by using 
either anti-DVAP to detect w.t. (C), and mutant DVAP or anti-Myc to detect Sac1 (C).  
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         3.4 Conclusion 
In order to investigate whether the analysis of the interaction between dSac1 
and DVAP can shed new light on the molecular mechanisms underlying ALS8 
pathogenesis, I confirmed this interaction in vitro by Co-IP. Interestingly, I 
observed that the two mutant forms of DVAP (DVAP-P58S and DVAP-T48I) 
retain their ability to bind Sac1 by Co-IP assay. The same result has been shown 
by yeast two-hybrid [Forrest et al., 2013]. Moreover, a detailed analysis of the 
domains of DVAP required for the interaction with Sac1, revealed that the MSP 
domain is dispensable for that interaction [Forrest et al., 2013]. The P58S and 
T48I mutations affect two amino acids that are placed in the ‘Vap consensus 
motif inside the MSP domain of VAP proteins [Nishimura et al., 2004]. Forrest 
et al., [2013] also have shown by yeast two-hybrid, that the TMD of DVAP is 
required for the interaction with Sac1. These data all together are in agreement 
with my results showing that P58S and T48I mutations do not affect the 



















In order to characterize the interaction between DVAP and Sac1 proteins, at 
first, this association has been confirmed by Co-IP in vitro (see Chapter 3 of this 
thesis). In order to move towards the study of Sac1 function in the nervous 
system the colocalization between DVAP and Sac1 in vivo using Drosophila 
melanogaster tissues and cultured cells. Previously, Sac1 protein was found 
associated to the ER and the Golgi complex in yeast and mammals [Whitters et 
al., 1993; Nemoto et al., 2000; Rohde et al., 2003; Tahrovic et al., 2005]. 
Manford et al.,[2010] suggested a functional model for Sac1. In this model TM1 
and TM2 domains of Sac1 allows Sac1 to be anchored to the ER and Golgi 
membranes. On the other hand, a cationic flexible loop allows the enzymatic 
site to work in trans to dephosphorylate PIPs on other membranes. 
Subsequently, Piao and Mayinger [2012] proposed that Sac1 localizes to the 
Golgi complex when the cell is under starvation condition in mammals and 
yeast (Fig. 7). When Sac1 translocates to the Golgi dephosphorylates PI4P to PI. 
The constitutive secretion and translocation of proteins to the PM is reduced 




Figure 7. Schematic view of the translocation of Sac1 phosphatase between ER and Golgi. 
Under mitogenic stimulation Sac1 moves from the Golgi apparatus to the ER. COPI vesicles are 
implicated in this translocation in mammals. On the other hand, under serum starvation 
conditions Sac1 phosphatase is brought from ER to Golgi by COPII vesicles. The figure is from 
Piao and Mayinger, 2012. 
 
In order to to assess the subcellular localization of Sac1 two approaches have 
been followed in parallel: the generation of an antibody against Sac1, and the 




4.2 Generation of anti-Sac1 antibody: the rationale for the choice of the 
translation vector and of the hexahistidine tag 
 
In order to generate an antibody recognizing Drosophila Sac1, it is crucial that 
an animal of choice develops a specific immune response against Sac1 protein. 
Thus, Sac1 protein needs to be produced and then injected into the animal. In 
order to produce a protein, first, a system where the protein can be expressed 
has to be chosen; second, the cDNA encoding the protein of interest has to be 
cloned into an expression vector. pET system has been chosen to produce Sac1 
as an antigen. This system allows expressing recombinant proteins in E. Coli. 
So far, E. Coli is the cheapest and fastest host cell in which to produce a 
recombinant protein. In order to maximize production of the recombinant 
protein a strain that lacks in lon and ompT proteases was used: BL21 (DE3) 
strain. In order to choose the expression vector in which to clone the cDNA, two 
considerations have been made: the need to produce a soluble or insoluble 
protein and the choice of the peptide to fuse to the protein to express. The need 
to produce a soluble protein comes from the necessity to have a protein in a 
native state. An antigen does not need to be in a native state, as in other 
applications, such as crystallography. On the other hand the production of an 
insoluble protein that, thus, localizes into cytosolic aggregates presents some 
advantages. These advantages include that the cytoplasmic aggregates can have 
a protective effect on the protein against proteolysis, although the bacterial 
strain in use (BL21 (DE3) strain) lacks two proteases. In addition, the inclusion 
bodies can be isolated by centrifugation and the protein can be solubilized using 
a detergent.  
 
The choice of the fusion tag has also been made taking into account the 
procedures that the produced protein should go through: purification of the 
protein from the entire pool of proteins of the cell, and the induction of the 
production of specific antibodies. The His-tag ((His)6) appeared to be a peptide 
that may be good in all the stages of the generation of an antigen. In fact, first, 
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the purification of a protein from the inclusion bodies has to be performed under 
denaturing conditions and the (His)6-tag is a peptide that is not affected by 
denaturing conditions. Second, the (His)6-tag is a small peptide (only six amino 
acids with an M.W. of 0.84 kDa) that is not highly antigenic. Although pET-28 
vector contains in its sequence (His)6-tag at both sides of the MCS, the Sac1 
cDNA was cloned into this vector in order to express a protein having the His-
tag at the N-terminus.  
 
4.2.1 Generation of the expression clone 
 
It is not always possible to express or, at least, to express a certain amount of a 
full-length recombinant protein to use as an antigen for the production of an 
antibody. Thus, different constructs encoding fusion proteins containing either 
the full-length Sac1 protein or Sac1 deletion derivatives were designed and 
generated in parallel [Graslund et al., 2008]. In expressing Sac1 deletion 
derivatives, N- and C-terminal boundaries were carefully chosen, as expression 
levels can be affected due to small differences in the length of the included 
protein regions [Graslund et al., 2008]. Therefore all Sac1 derivatives were 
designed by paying attention to the location of the SAC-domain and TM 
domains in the Sac1 amino acid sequence.  
 
Thus, after these preliminary considerations, a full-length Sac1 cDNA and five 
Sac1 deletion derivatives were cloned into the pET-28a expression vector. pET-
28 vector exists in three different reading frames (a-c) and we chose the pET-
28a. The expression cassette of the pET-28a expression vector, as in all the pET 
vectors is downstream of the promoter of the T7 RNA polymerase. The lac 
operator follows this promoter. Thus, the expression of the gene cloned in the 
expression cassette of this vector is induced when a lactose analog (IPTG) binds 
the repressor of the lac operator allowing the T7 RNA polymerase to start the 
transcription [Dubendorff et al., 1991]. The source of T7 RNA polymerase is 
the bacterial host cell.  
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Two Sac1 deletion derivatives using cDNA constructs encoding the N-terminal 
Sac1 portion were generated, and also, three constructs encoding the C-terminal 
portion of the protein. The two N-terminal Sac1 derivatives comprise the entire 
SAC-domain ((His)6-Sac1Δ483-594) (Fig. 8B), and the second construct 
contains the first five motifs of the SAC domain ((His)6-Sac1Δ354-594) (Fig. 
8C). All three Carboxyl-terminal Sac1 deletion derivatives include the two TM 
domains of the Sac1 protein (Fig. 8D-F). The first construct, (His)6-Sac1Δ1-
309, comprises motifs six and seven of the SAC domain, in addition to the two 
TM domains (Fig. 8D). The second construct (His)6-Sac1Δ1-267, includes the 
fifth, sixth and seventh motifs of the SAC domain and the two TM domains 
(Fig. 8E). The third construct, (His)6-Sac1Δ1-173, comprises motifs 3-7 of the 











Figure 8. Structure of all the His tag fusion-proteins that were generated to obtain the 
anti-Sac1 antibody. (A) Structure of the His tag-Sac1 fusion protein which includes the entire 
Drosophila Sac1 enzyme. The domains of Sac1 protein are shown. First, the SAC domain (121-
451aa) in light blue. Second, the seven motifs of the SAC domain are in dark blue: motif 1 (121-
143 aa), motif 2 (165-173 aa), motif 3 (182-240 aa), motif 4 (251-264 aa), motif 5 (287-309 aa), 
motif 6 (369-389 aa) and motif 8 (437-451 aa). Then, TM1 (524-540 aa) and TM2 (553-573 aa) 
domains are showed in green. The structures of the His tagged Sac1 deletion derivatives is also 
shown: (His)6-Sac1Δ483-594 (B), (His)6-Sac1Δ354-594 (C), (His)6-Sac1Δ1-309 (D) (His)6-
Sac1Δ1-267 (E), and (His)6-Sac1Δ1-173 (F). The protein schemes have been generated using 
DOG 1.0 software [Ren et al., 2009] 
 
4.2.1.1 Expression of the fusion proteins 
 
Five lysates from bacteria expressing the six different fusion proteins were 
resolved by SDS-PAGE, in order to perform a preliminary characterization of 
the expression levels of these proteins. The highest expression levels were 
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obtained with the two C-terminal Sac1 ((His)6-Sac1Δ1-309 and (His)6-Sac1Δ1-
267; Fig. 9B,C) deletion derivatives. Both (His)6-Sac1Δ1-309 and (His)6-
Sac1Δ1-267 fusion proteins localized to the inclusion bodies (Fig. 9C,E). 
(His)6-Sac1 (full-length) was not expressed at all (Fig. 9A). The two N-terminal 
Sac1 fusion proteins and the C-terminal (His)6-Sac1Δ1-173 were not expressed 
as highly as (His)6-Sac1Δ1-309 and (His)6-Sac1Δ1-267 tagged proteins (data 
not shown). 
 
The presence of the His-tag fused to the Sac1Δ1-267 fusion protein was 
checked by Western blot on BL(21)DE3 bacterial lysates using an anti-His 
antibody. These two proteins alternatively underwent a mild protein extraction 
from the inclusion bodies. A gentle protein extraction procedure using a mixture 
of zwitterionic and non-ionic detergents in a Tris buffer was preferred to the 
mechanical extraction of the protein obtained disrupting the membranes by 
sonication, to avoid protein disruption.  
 
Metal chelation chromatography approach was used to separate the His-tag 
fusion protein from the other proteins of the bacterial cell. The eluted His-
Sac1Δ1-267 tagged protein from the affinity column was quantified comparing 










Figure 9. Expression of  (His)6-Sac1, (His)6-Sac1Δ1-309 and (His)6-Sac1Δ1-267 fusion 
proteins in BL(21)DE3 bacterial strain. (A) Lysates from BL(21)DE3 bacteria transformed 
with pET28a-Sac1 and treated with IPTG to express the fusion protein (I=Induced) and not-
treated  with IPTG (UI=Uninduced). (B) Lysates from BL(21)DE3 bacteria transformed with 
Sac1Δ1-309. (C) Inclusion bodies (IB) and supernatant (SN) from lysates expressing His-
Sac1Δ1-309 fusion protein. (His)6-Sac1Δ1-309 (M.W.=32,05 kDa) is indicated by an arrow in 
(B) and (C). (D) Lysates from BL(21)DE3 bacteria transformed with pET28a-Sac1Δ1-267 and 
treated with IPTG to express the fusion protein (I) and not-treated  with IPTG (UI). (E) IB and 
SN from lysates expressing His-Sac1Δ1-267 fusion protein. (His)6-Sac1Δ1-267 (M.W.=36.94 
kDa) is indicated by an arrow in (D) and (E). (F) Amount of (His)6-Sac1Δ1-267 protein in the 
three elution fractions (E1, E2 and E3) were compared with four different BSA dilutions (3μg, 
2μg, 1.5 μg and 1μg) (His)6-Sac1Δ1-267 (M.W.=36.94 kDa) is indicated by an arrow in (c), (d) 
and (E). The protein schemes have been generated using DOG 1.0 software [Ren et al., 2009] 
 
4.2.1.2 Sac1 protein levels in wild type third instar larvae are under the 
detection limit for the anti-Sac1 antibodies  
 
The fusion protein was injected in rabbits and guinea pigs for antibody 
production. The 87-day immunization program was chosen in order to 
immunize the animal. The antigen was injected four times and four bleeds were 
collected during the 87 days. This program has been preferred to the 28-days 
immunization one, because a long immune response of the animal allows the 
generation of high affinity antisera, for use in immunohistochemistry 
experiments. In addition, the use of adjuvant compounds in the 28-days 
immunization program can affect the health of the animal.  
 
The sensitivity and specificity of the antisera in the bleeds collected from the 
two animals were tested, first, on wild type (CS) Drosophila embryos, on 
embryos from one line overexpressing Sac1 (UAS-Sac1133A), and, also, on 
embryos from one line having low levels of Sac1 (UAS-
Sac1RNAi/TM3,Sb,GFP) when compared to w.t. lines (data not shown). 
Nevertheless, we are interested in the characterization of the sub-cellular 
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distribution of Sac1 in particular in the nervous system of third instar larvae. 
Thus, Sac1 O.E. and Sac1RNAi transgene expression was targeted to the larval 
nervous system using the elav-Gal4 driver [Yao and White, 1994], and the 
sensitivity and the specificity of these antibodies were tested on brains, eye 
imaginal discs from CS, elav;Sac1133A and elav;Sac1RNAi larvae. In addition, 
the two anti-Sac1 antisera were also tested on larval salivary glands from the 
same genotypes, as elav-Gal4 driver directs the expression of transgenes also in 
larval salivary glands [Krueger et al., 2003].  
 
The immunohistochemical analysis revealed that the Sac1 antibody that was 
generated in guinea pig is able to detect Sac1 protein only in tissues from third 
instar larvae overexpressing Sac1 (elav;Sac1133A), but not from CS and 
elav;Sac1RNAi lines. The analysis of the antibody produced in guinea pig by 
Immunoblot on the same tissues from the three lines (CS, elav;Sac1133A, and 
elav;Sac1RNAi) (Fig. 10) confirmed what observed on the in vivo tissues.  
 
The anti-Sac1 antibody that was produced in rabbit, showed a strong 
background signal both in the immunohistochemical and Western blot analysis 
(data not shown). The background made it difficult to identify the Sac1 protein 
in tissues from all three of the analysed lines (CS, elav;Sac1133A, elav;Sac1
 
RNAi). In conclusion, the antibody developed in guinea pig is more specific that 
the one developed in rabbit, however, it is not sensitive enough for our 
experimental purposes.  
 
Figure 10. Sac1 levels in a physiological context are under the detection limit of the anti-
Sac1 antibody in guinea pig. Larval brains, salivary glands and eye imaginal discs from CTRL, 
elav;Sac1133A and elav;Sac1RNAi strains. The lysates were analyzed by Western Blot by using 




4.3 Generation of transgenic flies expressing Flag-Sac1 fusion protein 
4.3.1 Use of PhiC31 integration system to generate Flag-Sac1 transgenic 
flies 
 
As the two anti-Sac1 antisera that were generated lacked both specificity and 
sensitivity, transgenic flies expressing a tagged form of Sac1 were developed to 
look at the subcellular localization of Sac1. The PhiC31 integrase system 
[Bischof et al., 2007] was used for germ-line transformation with a UAS-Flag-
Sac1-attb construct (Fig. 11).  
 
Figure 11. Scheme of the construct that has been used to generate transgenic flies 
expressing flag-Sac1. The Sac1 cDNA (pink) has a flag-tag encoding sequence (green) 
upstream in frame. The flag-Sac1 transgene has been cloned in frame into the pUAST-attB 
vector. Figure adapted from Bischof et al., 2007.  
 
When this system is used, the integration of the heterologous DNA into the 
genome is mediated by a serine integrase, named PhiC31 integrase. PhiC31 
integrase is named after the bacteriophage whose genome encodes it. A number 
of reasons led us to choose this germ-line transformation system. First, this 
system allows site-specific integration of the transgene carried by the 
pUASTattB vector. The P-element mediated transgenesis which is the first 
method of transgenesis to be developed [Spradling, 1986] is characterized by 
transgene integration that is not site-specific. The transgene is often inserted in 
5’ regulatory regions leading to two major consequences: the local 
chromosomal environment can affect the expression of the transgene (position 
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effect) and inactivation of the transgene can occur because it can be inserted 
close to heterochromatin (position effect variegation) [Venken and Bellen, 
2007]. PhiC31 enzyme, on the other hand, catalyses the specific recombination 
between the ‘phage attachment’ (attP) site and the ‘bacterial attachment’ (attB) 
site (Fig. 12). Thus, the transgene integrates specifically where the attP site is 
placed in the fly strain genome. In this case, mapping of insertion of transgene 
is not required [Thorpe et al., 2000].  
 
When the recombination between the attP and attB sites occurs, the attB site is 
converted into an attR site, whereas the attP site is converted into an attL site. 
The new sites, attR and attL, are not recognized by the integrase, thus this 
enzyme will not mediate a reverse recombination between the two sites [Thorpe 
et al., 2000]. In addition, the PhiC31 integrase cannot catalyze the integration 
reaction between attB site and either attR or attL sites [Venken and Bellen, 
2007]. Thus, the integration reaction in this system is an irreversible event.  
 
Figure 12 Scheme of the site specific integration of the pUASTattB vector into the 
Drosophila genome. The PhiC31 integrase catalyzes the attB-attP combination. When the attB 
and attP sites recombinate they change their sequences creating two new sites (attR and attL) 
that are not recognized by the PhiC31 integrase. Thus, the transgene into the pUASTattB vector 
will be stably integrated into the specific Drosophila strain genome. Figure adapted from 
Bischof et al., 2007. 
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The transgene integration in the PhiC31 integration system was described to 
occur with high frequency (about 42.5%) [Bischof et al., 2007]. This percentage 
of integration frequency is considerably higher when compared to the one 
obtained with the P-element based integration frequency (about 1.6%) 
[Spradling, 1986]. 
 
The above described features led to the choice of PhiC31 integrase system to 
generate transgenic flies expressing Flag-Sac1 fusion protein. Thus, the Flag-
Sac1 was cloned into pUAST-attB vector and the insertion M{3xP3-RFP-
attP}ZH-22A [Bischof et al., 2007] integrated in the Drosophila genome (2L; 
22A) was designated as the first landing platform to use.  
 
4.3.1.1 Problems encountered using PhiC31 integration system 
 
Flies expressing Flag-Sac1 tagged protein were generated by using PhiC31 
integration system, although several disadvantages of these system were 
observed during the entire procedure. 
1. According to our data, the integration frequency was much lower than 
42.5%, as the pUASTattB-UAS-Flag-Sac1 construct was injected in about 4000 
embryos (200 embryos/day x 20 days) and only one transformant was 
generated.  
 
2. The identification of the actual transformant flies through the eye 
colour was weak and difficult to identify. The eye colour of the transformant 
ZH-attP-22A flies is reported to be light orange three days after eclosion 
[Bischof et al., 2007]. In addition, the eye color of non-transformant ZH-attP-
22A flies, usually, turns to pink in about three days time. This characteristic was 




3. Lastly, over several generations, the inserted transgene was lost in 
some flies, this evidence is in contrast with one of the most important hallmark 
of the PhiC31 integration system. The use of an integrase should avoid the 
transgene “jumping out” of the insertion site. 
 
All these considerations also led us to generate transgenic flies expressing Flag-
Sac1 tagged protein using the standard P-element transformation method. Four 
independent lines were generated, each one having the UAS-Flag-Sac1 
construct on one chromosome. 
 
4.3.1.2 DVAP and Sac1 associate in vivo 
 
In the first instance, ZH-22A-Flag-Sac1 flies were used to examine Drosophila 
Sac1 subcellular localization in vivo, while flag-Sac1 expressing lines were 
generated using the P-element transformation method by ‘Genetic Services, Inc. 
Drosophila Injections’. In Drosophila, it is possible to direct the expression of 
the transgene of interest in a time- and tissue- specific manner by using the 
UAS/GAL4 system [Brand and Perrimon, 1995]. To this aim, the expression of 
UAS-Flag-Sac1 transgene was driven pan-neuronally and in salivary glands by 
crossing the ZH-22A-Flag-Sac1 flies with elav-Gal4 driver [Yao and White, 
1994]. This driver not only directs transgene expression to the nervous system, 
but also to the salivary glands [Krueger et al., 2003]. DVAP and Flag-Sac1 
broadly co-localized in brains, eye imaginal discs, and salivary glands from 
third instar larvae (Fig.13 A,C,D).  
 
Furthermore, the UAS-Flag-Sac1 construct was expressed specifically in 
skeletal muscles using the BG57-Gal4 driver [Budnik, et al., 1996] where the 
association of these two proteins was also detected (Fig. 13B). Their distribution 
displays a peri-nuclear pattern resembling ER/Sarcoplasmic reticulum [Chen et 
al., 2010]. These results were confirmed by using the transgenic lines 
 105 
expressing Flag-Sac1 fusion protein (data not shown), which were generated 
using the standard P-element based integration system.  
 
Figure 13. DVAP and Sac1 widely associate in vivo. The in vivo colocalization of DVAP and 
Flag-Sac1 is shown in confocal images of (A) brains, (C) eye imaginal discs, (D) and salivary 
glands from elav;Flag-Sac1 (elav-Gal4/Y;UAS-Flag-Sac1/+ and elav-Gal4/+;UAS-Flag-
Sac1/+) third instar larvae.  The association is also detected in (B) muscles from BG57/ Flag-
Sac1 third instar larvae. The relevant tissues were stained with anti-DVAP (green) and anti-Flag 
(magenta) antisera. Image J software was used to analyze the signal from DVAP and Sac1 co-
localization. A pseudocolor (white) indicates the co-localization signal. The nuclei are indicated 







4.3 Sub-cellular localization of Sac1 phosphatase in COS-7 cells 
 
In mammals and yeast, Sac1 protein localizes to the ER and Golgi apparatus 
[Whitters et al., 1993; Konrad et al., 2002]. On the other hand, the yeast VAP-
33 homolog (Scs2) is confined to the ER [Kagiwada et al., 1998]. In addition, 
evidence from Drosophila and other experimental models shows that DVAP 
was found in association with microtubules and membranes [Pennetta et al., 
2002]. In particular, in mouse VAPs are associated to microtubules and 
intracellular vesicles in neurons [Skehel et al., 2000]; in rat VAP-33 homolog is 
proposed to function in the secretory pathway in the ER and the pre-Golgi 
compartment [Soussan et al., 1999]. Lastly, a VAP-33 homolog in plants was 
located mainly to the PM [Galaud et al., 1997; Laurent et al., 2000]. If it is true 
that Sac1 and DVAP interact in vivo they should colocalize. Thus, the intra-
cellular distribution of Sac1 was examined in COS-7 cells and it was compared 
to DVAP localization.  
 
To this aim, myc-DVAP and Flag-Sac1 tagged proteins were expressed in COS-
7 cultured cells. The constructs encoding these two fusion proteins were 
generated as described in the paragraph 3.1 of the Results section. 
Subsequently, COS-7 cells were co-transfected with both constructs and the two 
tagged proteins were visualized by fluorescence microscopy. In COS-7 cells 
myc-tagged DVAP follows an ER-like perinuclear reticular distribution (Fig. 
14A) according to previous findings [Chen et al., 2010]. On the other hand, 
Flag-tagged Sac1 protein presents both an ER distribution, similar to DVAP, as 
well as a paranuclear Golgi-like pattern (Fig. 14A). These data are in agreement 
with the sub-cellular localization of Sac1 protein at the Golgi complex reported 
in yeast [Whitters et al., 1993], in rat [Nemoto et al 2000], in mouse [Liu et al 
2008], and in humans [Rohde et al 2003]. No changes in the sub-cellular 
distribution of both proteins were observed in COS-7 cells that have been 
cotransfected with flag-tagged Sac1 and myc-tagged DVAP encoding constructs 
(Fig. 14B). In particular, the merge picture shows an overlapping between the 
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stainings of the two fusion proteins corresponding to an ER-like perinuclear 
reticular distribution (Fig. 14B). Additionally, a punctuate staining was 
observed in a fraction of COS-7 cells coexpressing myc-DVAP and flag-Sac1 










Figure 14. DVAP and Sac1 colocalize in the ER, but not in the Golgi. (A) Images from 
confocal microscopy of COS-7 cells alternatively transfected with Myc-DVAP and Flag-Sac1. 
Anti-Myc (green) and anti-Flag (white) antisera were used to visualize the proteins of interest. 
(B-C) Confocal images from COS-7 cells cotransfected with Myc-DVAP and Flag-Sac1. Anti-
Myc (green) and anti-Flag (magenta) antisera were used to visualize the proteins of interest. 10 
μm scale bar is used. N=Nucleus, G=Golgi apparatus, V= Vesicle-like structure.  
 
4.5 Sac1 localizes to the Golgi in third instar larval salivary gland cells 
 
The intracellular distribution of Sac1 in third instar larvae was examined in 
salivary gland cells from third instar larvae. The size of salivary gland cells is 
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much bigger (hundred of times) when compared to the majority of other cells in 
Drosophila [Andrew et al., 2000], thus, these cells are suitable to determine the 
subcellular localization of a protein. Flag-Sac1 transgene expression was 
targeted to the salivary glands by elav-Gal4 driver [Yao and White, 1994]. As 
Drosophila Sac1 presents a distribution pattern similar to the ER and the Golgi 
apparatus in COS-7 cells (Fig. 14A-B), Flag-Sac1 staining was compared to the 
staining pattern of the ER marker Boca [Culi and Mann, 2003], and the cys-
cisternal Golgi marker dGM130 (Fig.15B) [Kondylis et al., 2001]. Flag-Sac1 
staining largely overlaps with Boca (Fig. 15A) and GM130 stainings (Fig. 15B). 
This in vivo experiment confirmed the results obtained from colocalization 
experiment in COS-7 cells. Taken together these findings indicate that 
Drosophila Sac1 homolog distributes in the ER and in the Golgi apparatus, as 









Figure 15. Sub-cellular distribution of Sac1 phosphatase in vivo. Confocal images of salivary gland cells from elav;Flag-Sac1 (elav-Gal4/Y;UAS-
Flag-Sac1/+ and elav-Gal4/+;UAS-Flag-Sac1/+) third instar larvae. (A) Anti-Boca (green) and anti-Flag (magenta) anti-sera were used to stain the cells. 
Boca is an ER marker. (B) anti-dGM130 (green) and anti-Flag (magenta) antibodies were used to visualize the proteins of interest. dGM130 is a Golgi 




The interaction between DVAP and Sac1 is confirmed by the colocalization of 
these two proteins in several Drosophila larval tissues (brains, salivary glands, 
muscles and eye imaginal discs). However, when Drosophila larval tissues are 
examined, the extent of colocalization between the two proteins depends on the 
tissue. In fact, the stainings corresponding to DVAP and Flag-Sac1 extensively 
overlap in larval salivary glands and imaginal discs. On the other hand, Flag-
Sac1 and DVAP colocalize only partially in larval brains and eye imaginal 
discs.  
 
Moreover, the analysis of the subcellular distribution of DVAP and Sac1 in 
COS-7 cells reveal that these two proteins colocalize at the ER, whereas Sac1 
seems to localize also to the Golgi complex. Thus, DVAP and Sac1 may interact 
at the ER membranes. Previously, an ER and Golgi-like distribution has been 
reported for Sac1 also in mammalian cells and yeast [Whitters et al., 1993; 
Konrad et al., 2002; Liu et al., 2008]. Nevertheless, the localization of Sac1 to 
the Golgi or to the ER apparatus seems to be influenced in yeast by abundance 
of nutrients or starvation condition. The localization of Sac1 to different sites in 
the cell allows this phosphatase to control PI4P pools that are generated by 
different PI4 kinases in different sites of the cell [Faulhammer et al., 2007].  
Sac1 localizes at the contact sites between ER and PM when the nutrients are 
abundant. Here it dephosphorylates the PM-PI4P pool that is generated by Stt4 
kinase [Tahirovic et al., 2005]. The enzymatic activity of Sac1 at these 
membrane contact sites seems to be controlled by its interaction with Scs2p and 
Osh3 proteins. In fact, Osh3 has a PH domain that can sense PI4P levels directly 
binding them. Osh3 is an interacting partner of Scsp that stimulate the Sac1 
phosphatase activity when Osh3 senses high PM-PI4P levels [Stefan et al., 
2011]. Moreover, also VAP proteins present a PIP-binding motif in their 
sequence that bind PI4P in vitro [Kagiwada and Hashimoto, 2007]. This 
evidence suggests that also VAPs can sense PI4P levels by directly binding 
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them. Interestingly, this ‘PI4P binding motif’ partially overlaps with the ‘VAP 
consensus motif’, that is required for the interaction with the FFAT motif. This 
evidence suggests that the binding of PIPs to VAP proteins may affect the 
interaction with Osh3 that has a FFAT motif in its sequence. On the other hand, 
Sac1 localizes to the contact sites between ER and Golgi complex under 
starvation conditions [Faulhammer et al., 2007]. Here it controls Golgi-PI4P 
pool that is generated by Pik1p [Walch-Solimena et al., 1999]. The anterograde 
trafficking is down-regulated as a consequence of Sac1 reducing Golgi-PI4P 
pool. These data suggest that the cell growth conditions affect the trafficking 
capacity of the Golgi [Piao and Mayinger, 2012].  
 
In addition, we also observed the presence of vesicle-like structures where Sac1 
and DVAP localize in the cytoplasm of COS-7 cells transiently expressing two 
tagged forms of DVAP and Sac1. VAPA has been observed together with 
OSBP-related-protein 9 (ORP9) in vesicle-like structures in the cytoplasm of 
mammalian cultured cells [Wyles and Ridgway, 2004]. ORP9 contains a PH 
domain that binds PI4P [Ngo and Ridgway, 2009]. Moreover, VAP proteins are 
implicated in the positioning of late endosomes (LE). This happens through the 
alignment of the LE along the ER membranes. VAPs interact with OSBP-
related-protein 1 (ORP1) at the contact sites between ER and LE. These contact 
sites between ER and LE are transient and depend on the cholesterol levels. 
When there are low cholesterol levels the FFAT motif of ORP1 is available to 
interact with VAPs on the ER membrane. As a consequence the interaction 
between p150
Glued
, that is a subunit of dynactin1, that, in turn, belongs to the 
dynein complex, and Rab7 interacting lysosomal protein (RILP) on the LE is 
lost and the LE move towards the positive end of microtubules [Rocha et al., 
2009].  Dynein complex moves along the MTs through the interaction between 
its subunit p150
Glued
 and dynein protein [Muresan et al., 2001]. Dynein complex 
drives vesicle transport along the motor neuronal axons [Dion et al., 2009]. The 
vesicle-like structures we observed may be LE. In yeast, Sac1 seem to regulate 
LE trafficking, through its PI4P phosphatase activity [Tahirovic et al., 2005]. In 
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addition, in null Sac1 yeast mutant strains PI3P are increased. PI3P is among the 
phosphoinositides that can be dephosphorylated by Sac1 [Guo et al., 1999]. 
Moreover, PI3P localizes to endosomal membranes [Gillooly et al., 2000]. 
However, there are no evidence of the localization of Sac1 to the endocytic 
compartments, but it may transiently localize to the LE [Tahirovic et al., 2005]. 
The fact that ORP1 contains a PH domain binding PI4P lipids may suggest that 






















Chapter 5: Sac1 and DVAP control similar functions at the 
larval neuromuscular junction 
5.1 Introduction 
 
The interaction between Sac1 and DVAP has been showed both in vitro and in 
vivo. As I have analysed this interaction in order to elucidate the molecular basis 
of the motor neuron disease, ALS8, I investigated the functional relevance of 
this interaction at the site that is major target of motor neuron diseases: the 
neuronal muscular junction [Ferraiuolo et al., 2011]. Moreover, the Drosophila 
larval NMJ is a site of biological importance to DVAP protein [Pennetta et al., 
2002].  
 
Thus, in order to determine whether DVAP and Sac1 are components of the 
same molecular process, I examined the effects caused alternatively by Sac1 
LOF and DVAP LOF at the Drosophila larval NMJ pre- and post-synaptically. 
Subsequently, the phenotypes caused by both LOF have been compared 
between each other.  
 
5.2 Sac1 and DVAP loss-of-function alleles (LOF) lead to a change in the 
presynaptic morphology at the NMJ  
 
At first, the possibility that this interaction was functionally relevant at the NMJ 
was explored. Thus, the genetic interaction between Sac1 and DVAP was 
studied at the Drosophila larval neuromuscular junction. Here, DVAP drives 
synaptic sprouting by stabilizing microtubules within the boutons. A change in 
pre-synaptic morphology was observed in the NMJ of loss-of-function mutants 
for DVAP (DVAP
448
). These larval motor neurons present bigger but fewer 
boutons [Pennetta et al., 2002].  
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On the other hand, Sac1 is an essential gene that is required during gastrulation 
and the early phases of embryonic development. Thus, Sac1 LOF animals die as 
embryos [Wei et al., 2003], this precludes the possibility of using these LOF 
mutant animals to study Sac1 function at the NMJ. Drosophila NMJ is a highly 
powerful system to carry out studies on synapse function and development 
because each component of the synaptic terminal, the motor neuron and muscle 
cell, forms in a stereotypically consistent manner. In addition to the 
neuromuscular junction, neuronal arborisation is unique and highly identifiable 
[Collins et al., 2007].  
 
To bypass the embryonic lethality of Sac1 mutants, a transgenic RNAi approach 
was employed to reduce the expression levels of Drosophila Sac1 phosphatase 
[Fire et al., 1998]. The lack of a good antibody against Drosophila Sac1 did not 
give me the chance to check the Sac1 protein levels specifically in the tissues 
where Sac1 levels were decreased. Subsequently, the reduced levels of Sac1 
RNA compared to the CS larvae have been reported by Mario Sanhueza 
[Forrest et al., 2013].  
 
In order to look at the effect of reduced levels of Sac1 on the morphology of the 
presynaptic compartment of the NMJ, the expression of a UAS-Sac1RNAi 
transgene was driven pan-neuronally by using elav-Gal4 driver [Yao, and White, 
1994]. The larval muscles are organized in a stereotyped manner. Each 
abdominal segment is made of two specular hemisegments. Each abdominal 
hemisegment includes 30 skeletal muscles that are innervated by 40 motor 
neurons [Ruiz-Canada and Budnik, 2006]. The organization of muscles and 
motor neurons is repeated in each hemisegment [Crossley, 1978] with minor but 
noticeable differences. Thus, each skeletal muscle in the hemisegment is 
uniquely identifiable. Each motor neuron makes specific connections with the 
skeletal muscles in the hemisegment. The pre-synaptic bouton morphology of 
the NMJ of muscles 12 in the abdominal segment 3 (A3) of 3
rd
 instar larvae was 
examined. To look at the pre-synaptic shape of the larval NMJ, neurons were 
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stained with anti-HRP antibody. In Drosophila, anti-HRP staining allows to 
visualize the pre-synaptic arborisation profile (Fig. 16A), as this antiserum 
binds to carbohydrate lateral chains of several neuronal membrane proteins [Jan 
and Jan, 1982]. Interestingly, an increase in the size of boutons and a decrease 
in their number compared to control animals was observed (Fig. 16A-B). This 
phenotype recapitulates the one, previously reported at the NMJ from third 
instar larvae lacking DVAP [Pennetta et al., 2002].  
 
In particular, when the surface area in μm
2
 of the examined presynaptic boutons 
from elav;Sac1RNAi larvae was compared to control larvae, the bouton size of 
elav;Sac1RNAi larvae is, almost, twice the surface area of boutons from control 
larvae (Fig. 16C). Control larvae have a presynaptic bouton surface area of 5-10 
μm
2 
at the NMJ. Moreover, few boutons from control larvae have a surface area 
of 20-25 μm
2
, and no boutons over 25 μm
2
.  In contrast, elav;Sac1RNAi larvae 
present presynaptic boutons with a surface area of 5-25 μm
2
. Boutons with a 
surface area over 25 μm
2
 were consistently detected. Additionally, the 
quantification of the number of presynaptic boutons in elav;Sac1RNAi larvae 
was half the number of boutons which was observed in w.t. animals (Fig. 16D). 
The statistical analysis has been made by Mario Sanhueza.  
 
These findings show that when Sac1 phosphatase levels are decreased pre-
synaptically, the morphology of the synapse is affected. A similar phenotype 
was, previously, observed in DVAP loss-of-function (DVAP
448






Figure 16. Sac1 and DVAP interaction is functionally relevant. (A) Confocal images of muscle 12 from control larvae are compared to (B) confocal 
images of the same muscle from elav;Sac1RNAi (elav-Gal4/+;+/+;UAS-Sac1RNAi/+ and elav-Gal4/Y;+/+;UAS-Sac1RNAi/+) animals. The pre-synaptic 
compartment was stained with anti-HRP antiserum. (C) Bouton size and (D) bouton number were quantified in both controls and elav;Sac1RNAi animals. 
Frequency stands for the ratio between bouton number within a defined range of sizes and the total bouton number. The used scale bar is 10 μm. Error bars 
= s.e.m. ***P<0.001. 
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5.2 Sac1 is involved in stabilizing the MT network at the presynapsis of 
third instar NMJs 
 
The NMJ phenotype of down-regulating Sac1 at the presynaptic compartment 
(i.e. bigger, but fewer presynaptic boutons) phenocopies the DVAP KO 
presynaptic phenotype (DVAP
448
) [Pennetta et al., 2002], similar to that seen in 
futsch hypomorphic mutants [Roos et al., 2000]. Futsch encodes the Drosophila 
homolog of the Microtubule associated protein-1B (MAP1B) [Hummel et al., 
2000]. This protein is associated to microtubules and it is essential for 
stabilizing the hairpin loop structure that microtubules assume inside the bouton 
to promote bouton formation in the synapse [Miech et al., 2008; Roos et al., 
2000; Hummel et al., 2000]. In addition, either DVAP KO mutations or 
hypomorphic mutations in futsch present a quite altered MT cytoskeleton inside 
these bigger boutons. These findings are in agreement with the observation that 
both proteins directly interact with MT [Pennetta et al., 2002; Roos et al., 2000]. 
In particular, DVAP was proposed to act as a bridge between MTs and 
membranes [Pennetta et al., 2002].  
 
As the Sac1 protein is a direct interactor of DVAP, the integrity of the MT 
cytoskeleton network present in the large presynaptic boutons at NMJs from 
elav;Sac1RNAi larvae was examined. To this aim, UAS-Sac1RNAi transgenic 
construct was selectively expressed in the nervous system, using elav-Gal4 
driver [Yao and White, 1994]. The larval neuromuscular junction was double 
immunostained with anti-HRP [Jan and Jan, 1982], and anti-Futsch antisera. 
The anti-Futsch antibody corresponds to the mAb22c10 [Hummel et al., 2000] 
monoclonal antibody and it detects MAP1B in Drosophila. Anti-HRP staining 
allows the visualization of the change in bouton size and number when Sac1 
levels are decreased. Anti-Futsch staining appeared as a filament that runs 
through the NMJ presynaptic branches in control animals [Godena et al., 2011] 
(Fig. 17A). When Sac1 expression levels are diminished, the change in 
presynaptic staining pattern of Futsch is altered (Fig. 17C). The futsch-positive 
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filaments do not traverse continuously along the presynaptic processes anymore 
but appear more fragmented and sometimes punctuated, especially in boutons 
that are more distant from the branching point at the axon terminal (Fig. 17C). 
Simultaneously, the microtubule organization was examined in the same way in 
larval NMJs from animals having decreased levels of DVAP in the nervous 
system (elav;DVAPRNAi). Likewise, big boutons at the NMJ of mutant third 
instar larvae were associated with MT fragmentation at the presynaptic 
ramifications (Fig. 17B).  
 
Taken together these results show that the altered presynaptic morphology 
detected at NMJ from mutant larvae with low Sac1 levels, is associated with an 
altered presynaptic MT architecture. These findings are in agreement with the 
results reported earlier in this Results section showing that Sac1 interacts in 












Figure 17. Sac1 has a role in stabilizing microtubules at the NMJ. The confocal images show the synapses of muscle 12 from (A) control larvae, (B) 
elav;DVAPRNAi (elav-Gal4/+; +/+;UAS-DVAPRNAi/+ and elav-Gal4/Y; +/+;UAS-DVAPRNAi/+) larvae, and (C) elav;Sac1RNAi (elav-Gal4/+; 
+/+;UAS-Sac1RNAi/+ and elav-Gal4/Y; +/+;UAS-Sac1RNAi/+) larvae. The presynaptic compartment was stained with anti-HRP, and anti-Futsch 
antisera. The arrowheads indicate boutons with punctuate Futsch staining, whereas arrows indicate boutons with Futsch staining accumulation. The scale 
bar used is 10 μm. Error bars = s.e.m. ***P<0.001. 
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5.3 Sac1 and DVAP are involved in vesicle trafficking in the axons of motor 
neurons 
 
MTs are fundamental components of the axon terminal, stabilizing the 
presynaptic branches and controlling the presynaptic bouton budding [Tanaka et 
al., 1995]. In particular, the MTs are arranged in bundles with uniform 
orientation in the axons of motor neurons. In the axons these MT bundles are 
involved in axonal polarization and axonal growth [Conde and Caceres, 2009].  
 
Given that Sac1 seems to be implicated in preserving the MT network within 
the presynaptic boutons, the chance that Sac1 has a similar role on the axonal 
MTs was explored. Moreover, this possibility has never been tested also for 
DVAP. To answer these questions, the possibility that decreased levels of either 
Sac1 or DVAP in the nervous system could perturb MT organization in the 
axons was tested.  
 
Control and elav;Sac1-RNAi third instar larval NMJs were stained with both 
anti-HRP [Jan and Jan, 1982] and anti-Futsch antibodies. A continuous Futsch-
positive thread was observed in control larvae running through the axon to the 
branching point where it divides into several branches. The microtubule 
organization in the axons did not appear to be affected in elav;Sac1RNAi larvae 
motor neuron (data not shown). In addition, the same experiment was carried 
out in parallel on elav;DVAPRNAi third instar larval NMJs. As with Sac1 down 
regulation, no differences in axonal microtubule structure were detected in 
axons from larvae having low DVAP levels in the nervous system 








Figure 18. Diagram of T-bars. (A) represents a schematic representation of brp proteins 
associated to the presynaptic membrane and forming the T-bar together with presynaptic 
vesicles. (B) T-bar is shoed by Scanning Electron Microscopy. The two white arrowheads show 
the sides of the T-bar. Figure adapted from Toonen and Verhage, 2011 
 
Nevertheless, the effect of low levels of Sac1 or DVAP on axonal vesicle 
transport was examined by staining NMJs from elav;Sac1RNAi and 
elav;DVAPRNAi mutant third instar larvae with the antibody against bruchpilot 
(brp) protein. Brp is the Drosophila homolog of ELK/CAST/ERC protein, 
which resides in the active zones and binds “T-bars” complex (Fig. 18) [Wagh 
et al., 2006; Kittel et al., 2006]. T-bars are cytoplasmic projections that facilitate 
the flow of the presynaptic vesicles to the active zones at synapses, 
characterized by a high vesicle release [Johnson III et al., 2009]. Some proteins 
have been identified in these cytoplasmic projections of vertebrates, whereas 
Brp is the only protein to be known in this site in Drosophila [Johnson III et al., 
2009]. Sac1 protein was knocked-down by using the UAS-Sac1RNAi transgenic 
construct in the nervous system by using the elav-Gal4 driver [Yao and White, 
1994]. Double staining was carried out on larval motor neuron axons by using 
anti-HRP [Jan and Jan, 1982] and anti-Brp antisera [Hofbauer et al., 2009]. Brp 
staining in motor neuron axons from control larvae was virtually absent (Fig. 
19A), whereas elav;Sac1RNAi transgenic animals showed Brp-positive puncta 
(Fig. 19C). Analysis of the nerve from elav;DVAPRNAi larvae stained with anti-
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HRP and anti-Brp showed that although Brp-positive puncta were observed in 
the axons of NMJs from these transgenic larvae, they were less evident 
compared to the Brp-positive puncta found in elav;Sac1RNAi larvae (Fig. 19B). 
Moreover, quantification of the Brp signal in axons from control, 
elav;DVAPRNAi and elav;Sac1RNAi larvae indicated a big difference between 
the number of Brp-positive puncta of the mutant larvae and the control larvae 
(Mario Sanhueza, Fig. 19D).  
 
These data suggest that Sac1 has a role in the transport along the motor neuron 
axons. In order to explore this hypothesis in depth, motor neuron axons from 
control, elav;Sac1RNAi, and elav;DVAPRNAi were stained with an antibody 
against a protein which has an important role in the transport of vesicles through 
the axons: Cysteine String Protein (CSP) [Zinsmaier et al., 1994]. NMJs from 
the three different genotypes were stained with anti-HRP and anti-CSP, and 
they were compared between each other. Elav;Sac1RNAi, and elav;DVAPRNAi 
transgenic larvae presented CSP-positive accumulations in motor neuronal 
axons (data not shown).  
 
These findings support the hypothesis that the function of both Sac1 and DVAP 





Figure 19. Low Sac1 and DVAP levels induce Brp aggregates in the motor neuron axons. Confocal images of motor neuron axons on muscle 12 from 
(a) CTRL, (b) elav;Sac1RNAi (elav-Gal4/+; +/+;UAS-Sac1RNAi/+ and elav-Gal4/Y; +/+;UAS-Sac1RNAi/+), and (c) elav;DVAPRNAI (elav-Gal4/+; 
+/+;UAS- DVAPRNAI/+ and elav-Gal4/Y; +/+;UAS- DVAPRNAI/+) larvae. The axons are stained with anti-HRP, and anti-CSP. The scale bar used is 10 
μm. (d) Quantification of Brp signal in nerves of the CTRL, elav;Sac1RNAi (elav-Gal4/+; +/+;UAS-Sac1RNAi/+ and elav-Gal4/Y; +/+;UAS-
Sac1RNAi/+), and elav;DVAPRNAI (elav-Gal4/+; +/+;UAS- DVAPRNAI/+ and elav-Gal4/Y; +/+;UAS- DVAPRNAI/+) larvae. s.e.m.***P<0.001 is 
symbolized by error bars
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5.4 Sac1 and DVAP are required for the proper localization of adducin and 
β-spectrin 
 
Following the analysis of the interaction between DVAP and Sac1 at the 
presynaptic compartment of the larval NMJ, Sac1 function was examined also 
in the postsynaptic compartment of the NMJ. Thus, the effect of reduced Sac1 
and DVAP levels on adducin, β-spectrin and DLG proteins that have been well 
characterized postsynaptically at the Drosophila larval NMJ, and have been 
found implicated in neurodegeneration, was analyzed. These three proteins 
belong to the spectrin-actin cytoskeleton (Fig. 20) that is placed under the 
plasma membrane of the post-synaptic compartment supporting the presynaptic 
compartment of the NMJ.  
 
Figure 20. Schematic representation of the Adducin, β-spectrin, Dlg and actin in the 
spectrin-actin cytoskeleton of the post-synaptic compartment. Add = adducin, Dlg = discs 
large protein. Figure adapted from Wang et al., 2011.  
Adducin has an actin-capping activity [Pielage et al., 2011]. In Drosophila, one 
gene (hu-li tai shao, also named hts) encodes for one adducin protein [Robinson 
et al., 1994]. In vertebrates three genes encode adducin proteins: α-adducin, β-
adducin and γ-adducin [Matsuoka et al., 2000]. The effect of Sac1 and DVAP 
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functions on adducin distribution pattern was examined for the following 
reasons. First, impairment in synaptic plasticity and learning was observed in 
mice where the function of β-adducin was abolished [Shan et al., 2005]. 
Moreover, adducin has been recently shown to play a key role in synaptic 
stability in mice and Drosophila [Bednarek and Caroni, 2011; Pielage et al., 
2011]. Lastly, PKC kinase is required to phosphorylate adducins and high levels 
of phosphorylated α-adducin and γ-adducin in association with high levels of 
PKC were observed in ALS patients [Hu et al., 2003]. Interestingly, PKC 
activity is induced by a number of lipid molecules including PIPs [Hu et al., 
2003].  
 
β-spectrin together with α-spectrin and short actin fragments form a network 
called ‘spectrin skeleton’ that anchors to the membrane through the interaction 
with PM-PIPs and PM-proteins [Pielage et al., 2006; Zhang et al 1995]. The 
interaction of β-spectrin is mediated by the PH domain in β-spectrin sequence 
[Zhang et al 1995]. It has been proposed that the spectrin skeleton acts as a 
frame around the presynaptic compartment [Pielage et al., 2006]. Interestingly, 
mutations in the domain of β-spectrin implicated in the interaction with actin 
were identified in some Spinocerebellar Ataxia type 5 (SCA5) patients [Ikeda et 
al., 2006].  
 
In order to analyze the effect of diminished expression levels of Sac1 
phosphatase and DVAP on adducin in the postsynaptic compartment at the 
larval NMJ, the expression of UAS-Sac1RNAi and UAS-DVAPRNAi transgenes 
was selectively directed by using the BG57-Gal4 driver [Budnik et al., 1996]. 
The NMJ presynaptic compartment profile of wild-type and transgenic larvae 
was delineated by the use of an antibody against HRP. On the other hand, 
Drosophila adducin in the post-synaptic compartment was visualized through an 
anti-Hts antiserum (anti-Hts1B1) [Petrella et al., 2007]. In control animals 
postsynaptic adducin is especially concentrated at the sub-synaptic reticulum 
(SSR) membrane folds around the presynaptic membrane (Fig. 21A) [Pielage et 
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al., 2011]. In w.t. animals the anti-HRP antibody delineates the presynaptic 
membrane that has boutons with regular rounded shape, and they are uniformly 
arranged along the motor neuron ramification, as “beads on a string” –like 
organization (Fig. 21A) [Johansen et al., 1989]. In BG57;DVAPRNAi larvae the 
pre-synaptic membrane morphology is highly deformed showing boutons with 
irregular profile and bigger size. In addition, the adducin distribution pattern is 
clearly perturbed (Fig. 21B). Likewise, diminished Sac1 levels in the 
postsynaptic compartment cause a change also in the presynaptic profile, and 
altered adducin localization (Fig. 21C).  
 
In order to further examine the functional relevance of the association between 
Sac1 and DVAP, larval NMJs from BG57;Sac1RNAi and BG57;DVAPRNAi 
were dissected and double-stained with anti-HRP and anti-β-spectrin antisera. 
As adducin and β-spectrin interact with each other to stabilize the spectrin-actin 
cytoskeleton in the postsynaptic compartment [Bennett et al 1988; Kuhlman et 
al 1996], wild type larvae displayed a β-spectrin staining that closely follows the 
adducin localization pattern (Fig. 21D). When Sac1 levels were lowered in 
muscles (BG57;Sac1RNAi), larval NMJs presented an unusual diffuse β-spectrin 
distribution when they were compared to control larvae (Fig. 21F). Similarly, an 
abnormal and irregular β-spectrin distribution pattern was detected in 
BG57;DVAPRNAi third instar larval muscles. Also in this case β-spectrin 
staining no longer defines and surrounds the presynaptic membrane (Fig. 21E).  
 
The possibility that Sac1 and DVAP down-regulation in the postsynaptic 
compartment can affect the distribution of discs large (DLG) was also explored. 
DLG, the Drosophila homolog of PSD (post-synaptic density) -95, is a well-
characterized postsynaptic protein and it functions in a complex with adducin 
and β-spectrin, and depends from these two proteins for its proper postsynaptic 
distribution [Wang et al., 2011; Featherstone et al., 2001; Lahey et al., 1994]. 
Larval NMJs from BG57;DVAPRNAi and BG57;Sac1RNAi were double-labeled 
with anti-HRP and anti-DLG antibodies. Postsynaptic DLG distribution appears 
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to be altered in both transgenic mutant larvae (Fig. 21G-I), in much the same 
way as for the previously examined post-synaptic markers. 
  
Nevertheless, besides the changes in the postsynaptic marker distribution 
patterns, when DVAP and Sac1 are reduced in the postsynaptic compartment of 
the NMJ, altered bouton shape of the presynaptic compartment is observed (Fig. 
21). In control animals, the morphology of boutons consists of a well-defined 
and oval shape with neuronal process separating the bouton from each other. 
When the levels of both DVAP and Sac1 are down-regulated, boutons present 
an abnormal appearance. Intriguingly, they display a bigger size and exhibit 








 Figure 21. Postsynaptic Adducin, β-spectrin and adducin localization is altered when Sac1 and DVAP are down-regulated selectively in muscles. 
Confocal images from (A,D,G) CTRL, (B,E,H) BG57;DVAPRNAI
GD3990
 (BG57-Gal4/+;UASDVAPRNAI/+), and (C,F,I) BG57;Sac1RNAi (BG57-
Gal4/+;UAS-Sac1RNAi/+) larvae. In (A-C) third instar larval NMJ were stained with anti-HRP and anti-adducin (anti-HTs1B1) antisera. In (D-F) third 
instar larval NMJ were stained with anti-HRP and anti-β-spectrin antibodies. In (G-I) third instar larval NMJ were stained with anti-HRP and anti-DLG 
antisera. Missing or diffused post-synaptic staining is indicated by arrows, whereas spike-like protrusions are indicated by arrowheads. The scale bar 




Sac1 function appears to be fundamental for proper presynaptic membrane 
shape at the Drosophila larval NMJ. Interestingly, low levels of Sac1 at the pre 
and postsynaptic compartments result in changes of presynaptic membrane 
shape. On the one hand, the altered PM membrane shape seems to be caused by 
the altered MT organization in the presynaptic boutons. On the other hand, the 
delocalization of important components of the spectrin-actin cytoskeleton, such 
as adducin, β-spectrin and DLG, underlying the postsynaptic PM, also seems to 
affect the shape of the presynaptic membrane. Both disruption of the MT 
organization of MT cytoskeleton in the presynaptic boutons, and altered 
organization of the spectrin-actin cytoskeleton in the muscles are consequences 
of decreased levels of Sac1 respectively. Nevertheless, the extent of the shape 
alteration is different according to the compartment of the Drosophila larval 
NMJ where the Sac1 levels where decreased. In fact, when Sac1 was decreased 
in the presynaptic compartment, the MTs into the boutons were disorganized, 
and the bouton appeared smaller than wt ones. When Sac1 levels were lowered 
in the postsynaptic membrane, and, consequently, the adducin, β-spectrin and 
DLG were mislocalised in the muscles, the presynaptic membrane appeared 
deformed with spike-like protrusions.  
 
Intriguingly, low levels of Sac1 in the presynaptic membrane are not only 
associated to altered MT cytoskeleton inside the presynaptic boutons but also to 
the accumulation of vesicles into the axons of motor neurons. It is not clear 
which is the relationship between the two phenotypes observed at the 
presynaptic compartment of the NMJ.  
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So far, the interaction between DVAP and Sac1 has been examined in vitro and 
in vivo. The analysis of this interaction in vivo not only has been performed 
showing the colocalization between the two proteins both in COS-7 cells and 
Drosophila larval tissues, but also looking at the involvement of the functions of 
DVAP and Sac1 in similar pathways at the larval NMJ. The NMJ is the site that 
is most severely affected in motor neuron diseases [Ferraiuolo et al., 2011].  
 
Interestingly, Forrest et al., [2013] showed that high levels of PI4P in muscles, 
brains and salivary glands are associated to both decreased levels of Sac1 and 
expression of DVAP-P58S in the nervous system. PI4P is the substrate of Sac1 
phosphatase, and high levels of PI4P can be associated to an impaired Sac1 
activity. Therefore, as both DVAP-P58S and low levels of Sac1 lead to high 
levels of PI4P, I decided to investigate whether decreased levels of Sac1 as 
DVAP-P58S could cause neurodegeneration.  
 
6.2 Decreased Sac1 expression levels lead to neurodegeneration 
 
In order to address examine whether Sac1 is implicated in neurodegenerative 
processes, the levels of Sac1 phosphatase were turned down selectively in the 
nervous system. Thus, the expression of UAS-Sac1RNAi was targeted to the 
nervous system under the control of the pan-neuronal driver elav-Gal4 [Yao and 
White, 1994]. At first, the viability rate (females observed/females expected) of 
elav;Sac1RNAi transgenic animals was recorded. Mutant flies were monitored 
over the different developmental stages, and the males eclosed into adults at the 
50% of the expected Mendelian ratio. This experiment showed that Sac1, as 
DVAP, affect the developmental process of Drosophila. This evidence suggests 
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that can play a role in neurodegenerative processes and that the amount of Sac1 
phosphatase is inversely proportional to neurodegeneration.  
  
Intriguingly, necrotic patches at the legs joints of elav;Sac1RNAi transgenic 
males were also observed (data not shown). It is possible that this patches can 
make the legs more fragile, and, thus, sensitive to breakage. Moreover, 
elav;Sac1RNAi male flies encounter early death between the 3
rd
 and the 4
th
 day 
from eclosion. In addition, an obvious degeneration was detected in the eyes of 
these flies (Fig. 22A); nevertheless, females and males displayed different 
intensity of this phenotype. In fact, elav-Gal4/Y;UAS-Sac1RNAi males present 
necrotic patches which covered almost the entire area of the eye. The penetrance 
of this phenotype is 100%, however, the patches of necrosis on the eyes of 
males displayed differences regarding their extent of damaged tissues and 
number of patches (Fig. 22A). On the other hand, elav-Gal4/+;UAS-Sac1RNAi 
females present depigmentation all over the eye surface (Fig.22A). The dosage 
compensation is the reason why such a difference in the phenotype is recorded 
between males and females [Warrick et al., 1999]. To double check whether the 
degenerative effect of decreased levels of Sac1 was genuine or the elav-Gal4 
contributed to this phenotype, the appearance of eyes from elav-Gal4/Y and 
elav-Gal4/+ transgenic flies was examined. In this case, the presence of the 
driver did not affect the integrity of the eye structure (data not shown).  
 
Evidence about the involvement of Sac1 phosphatase in neurodegeneration was 
reported as a consequence of the expression of a hypomorphic allele of Sac1 
[Wei et al., 2003]. It was not possible to reproduce the degenerative phenotype 
due to this allele, because this hypomorphic allele is lost and not longer 
available. However, it has been shown, independently, that decreased levels of 
Sac1 are associated with neurodegeneration. These data mean that the 
neurodegeneration observed in flies having lower levels of Sac1 in the nervous 
system is authentic, and it is not due to off-target effects. 
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The adult eyes from elav-Gal4/Y;UAS-Sac1RNAi transgenic male flies have also 
been examined by SEM analysis. Thus, it is possible to visualize the 
architecture of ommatidia that is highly disorganized when compared to the 
eyes of control flies (Fig. 22B). Additionally, the SEM analysis also showed 
that mechano-sensory bristles appear sometimes supernumerary and sometimes 
missing whilst adult eyes are regularly distributed among the ommatidia in CS 
flies (Fig. 22B).  
 
Finally, the extent of the degeneration of the adult Drosophila eye from elav-
Gal4/Y;UAS-Sac1RNAi transgenic male was examined also by looking at the 
internal structure of the eye by histological analysis. The retina is completely 
lost, with only few fragments of photoreceptors left (Fig. 22C). On the other 
hand, an organized array of photoreceptors is visible beneath the eye surface in 










Figure 22. Decreased Sac1 levels cause dosage-dependent neurodegeneration. (A) Control, 
elav;Sac1RNAi (elav-Gal4/Y;+/+;UAS-Sac1RNAi/+) males and elav;Sac1RNAi (elav-
Gal4/+;+/+;UAS-Sac1RNAi/+) females adult eyes (Stereomicroscope images). (B) Control eyes 
and elav;Sac1RNAi transgenic eyes of adult males (SEM images). (C) Control eyes and 
elav;Sac1RNAi transgenic eyes of adult males (Paraffin sections). 10 μm are represented by 






6.3 Progressive neurodegeneration is observed when Sac1 is lowered in the 
adult Drosophila brain  
 
It has been reported in this thesis that low levels of Sac1 phosphatase in the 
nervous system are associated with a neurodegenerative phenotype. ALS is a 
motor neuron disease that is characterized by a progressive worsening of the 
symptoms [Ferraiuolo et al., 2011]. The possibility that a progressive 
neurodegeneration was observed when Sac1 levels where lowered selectively in 
the nervous system was explored. To this aim, the internal structure of the optic 
lobe from elav;Sac1RNAi adult flies was analysed through paraffin sections. In 
control flies, the structure under the retina is organized showing a tidy 
organization of the three optic ganglions (Lamina, Medulla, and Lobula) (Fig. 
23A). In newly hatched flies expressing UAS-Sac1RNAi in the nervous system, 
an altered structure of the optic lobe is evident (Fig. 23B). The structure of the 
optic lobe is completely missed in 36-48h old elav;Sac1RNAi flies (Fig. 23C). 
Vacuolisation is also observed in addition to the collapse of the photoreceptor 
array (Fig. 23C). In conclusion, a progressive neurodegeneration is associated 
with decreased levels of Sac1 in the nervous system and the adult Drosophila 








Figure 23. Reduced levels of Sac1 in the nervous system causes progressive neurodegeneration. Histological analysis of the internal structure of the 
optical lobes was performed on control adult flies (A), newly hatched elav;Sac1RNAi adult flies (B), and 36-48h old elav;Sac1RNAi adult flies (C).   
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6.4 Mutant DVAP retains its ability to bind Sac1 in vivo 
 
The interaction between the mutant form of DVAP, DVAP-P58S, and Sac1 
phosphatase has been shown in vitro by yeast two-hybrid assay [Forrest et al., 
2013] and by Co-IP [in this thesis]. Moreover, the expression of both DVAP-
P58S and DVAP-T48I is associated with the formation of DVAP-positive 
aggregates in vitro as well as in vivo [Teuling et al., 2007; Chai et al., 2008; 
Tsuda et al., 2008; Ratnaparkhi et al., 2008; Chen et al., 2010]. Thus, if the 
interaction between Sac1 and DVAP is not disrupted by the P58S mutation in 
DVAP, the possibility that Sac1 localizes into DVAP-positive aggregates has 
been explored. The expression of UAS-Flag-Sac1 transgenic construct was 
directed to the eyes by using the ey-Gal4 driver in a DVAP-P58S background. 
Eye imaginal discs from Ey;UAS-DVAP-P58S/Flag-Sac1 third instar larvae 
were double-stained with anti-DVAP and anti-Flag antisera (Fig. 24A). 
Likewise, when UAS-Flag-Sac1 construct was expressed specifically in the 
nervous system by using elav-Gal4 driver [Yao and White, 1994] in the 
presence of DVAP-P58S (elav;DVAP-P58S;Flag-Sac1), Sac1 was captured into 
the DVAP-positive cytosolic aggregates (Fig. 24B). These data further confirm 
that Sac1 is mislocalised when DVAP-P58S is expressed as it is trapped into 




Figure 24. Sac1 is recruited in DVAP cytoplasmic inclusions. (A) Eye imaginal discs from Ey;UAS-DVAP-P58S/Flag-Sac1 third instar 
larvae were. (B) Brains from third instar elav;DVAP-P58S;Flag-Sac1 larvae. Both DVAP and DVAP-58S are stained with an anti-DVAP 




When Sac1 levels are decreased in the nervous system a progressive 
neurodegenerative phenotype is observed in third instar larvae. This evidence 
suggests that the altered developmental process observed in flies having low 
levels of Sac1 in the nervous system can be a consequence of the 
neurodegeneration. The fact that Sac1 has been detected into DVAP-P58S 
positive aggregates both in larval eye imaginal discs and brains, suggests a 
molecular mechanism underlying DVAP-P58S mediated neurodegeneration 
[Chen et al., 2010]. Sac1 maybe trapped into the aggregates caused by the 
expression of DVAP-P58S, and, thus, a context characterized by low levels of 
Sac1 can be mimic. This hypothesis is supported by the fact that DVAP-P58S 
mutant protein interacts with Sac1 phosphatase. Moreover, increased levels of 

































DISCUSSION AND,  












         Chapter 7: Discussion 
7.1 Introduction 
Flies expressing mutant alleles of DVAP that cause ALS8 in humans present the 
major characteristics of the disease, such as neuronal death, formation of 
aggregates in the motor neurons, locomotion defects and neurodegeneration 
[Chai et al., 2008; Chen et al., 2010]. Moreover, the phenotypes associated to 
the expression of DVAP-P58S are rescued by the transgenic expression of 
hVAPB [Chai et al., 2008]. This means that the function of VAP proteins is 
evolutionary conserved, and, thus, studying the cellular processes in which 
DVAP is implicated can be useful in understanding the cellular functions of 
hVAPB. This information can be used to understand the molecular mechanisms 
underlying the pathogenesis of ALS8 in humans.  
 
In this PhD thesis I focused on the cellular pathways at the larval Drosophila 
NMJ that are regulated by the interaction between DVAP and Sac1, and on the 
role of this interaction in ALS8 pathogenesis. Initially, the interaction between 
these two proteins was identified during a genome-wide yeast two-hybrid assay 
by Dr. Katherine Parry and it has been thoroughly confirmed by co-
immunoprecipitation, and colocalization in vivo between these two proteins. 
Moreover, when DVAP levels or Sac1 levels are decreased, similar phenotypes 
are observed. The similarity in the phenotypes suggests that the two genes 
control the same pathways. In yeast, VAP proteins stimulate the enzymatic 
activity of Sac1 in vivo and in vitro [Stefan et al., 2011], supporting the 
hypothesis that these two proteins are implicated in the same pathways. 
 
7.2 DVAP and Sac1 control the stabilization of the MT scaffold in the 
presynaptic boutons at the NMJ 
 
At the presynaptic compartment low levels of Sac1 as low levels of DVAP alter 
synaptic morphology and the MT organization inside the synaptic boutons. The 
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role of DVAP in maintaining the synaptic morphology as a consequence of its 
role in stabilizing the interaction of MTs to the plasma membrane inside the 
synaptic boutons has been previously shown in DVAP null Drosophila larvae 
[Pennetta et al., 2002]. Evidence in the literature shows the involvement of PIs 
in MT stabilization and disassembly. In particular, MT structure is destabilized 
by PIs-enriched micelles in vitro [Yamauchi and Purich, 1987]. These micelles 
have a negative charge around their surface and that reduces the interaction 
between Microtubule-associated-protein 2 (MAP-2) proteins and MT 
[Yamauchi and Purich, 1987]. MAP-2 is a protein family that is abundantly 
expressed in the nervous system and that binds MTs [Sanchez et al., 2000]. MT 
nucleation and stabilization are among the cellular functions that MAP-2 is 
needed for [Sanchez et al., 2000]. If PIs may reduce the association of MAP-2 
to the MT filaments, and, in turn, MT may become less stable in the presence of 
high levels of PIs. Moreover, low levels of Sac1 in cultured cells perturbed the 
MT filaments of the mitotic spindle in cultured cells. In fact, the mitotic spindle 
presents many poles as a consequence of many MT nucleation sites [Liu et al., 
2008].  
 
PIPs are implicated in the stabilization of MTs to particular area of the plasma 
membrane during the cell motility process. Rafts containing PI(4,5)P2 and the 
small GTPase, Cdc42, recruit the positive ends of MT filaments to the PM. The 
recruitment of this MT filament further promotes the formation PIP-enriched 
rafts [Golub and Caroni, 2005]. Interestingly, synapses formation seems to 
present similarities at the phenomenological level and sometimes at the 
molecular levels with the cell motility process [Weston et al., 2000].  
 
In addition, the actin cytoskeleton is required for the structural integrity of MT 
cytoskeleton [Lin and Forscher, 1993] and growth cones of motor neurons are 
characterized by the presence not only of the MT filaments, but also of actin 
scaffolds [Schaefer et al., 2002]. Several aspects of the actin cytoskeleton 
organization (actin nucleation, actin filament elongation, and interaction 
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between actin filaments and membrane) are controlled by PIPs [Di Paolo and 
De Camilli, 2006]. PI(4,5)P2 is required for the recruitment of actin to the PM 
[Pollard et al., 2003]. The same PIP induces the dissociation of actin-capping 
proteins from the actin filaments stimulating filament elongation [Yin et al., 
2003]. Then, PI(4,5)P2 also enhances the affinity between adhesion proteins of 
the PM and FERM-domain adaptor proteins [Di Paolo and De Camilli, 2006]. 
The FERM domain binds PIPs and the proteins containing this domain are 
implicated in the association between actin filaments and PM [Hamada et al., 
2000]. PI4P is required for the generation of PI(4,5)P2, thus, Sac1 enzymatic 
activity can control the MT cytoskeleton through the stabilization of actin 
filaments. Thus, when Sac1 function is impaired, the destabilization of MT 
cytoskeleton can depend on destabilization of actin filaments.  
 
The importance of MT scaffold is also shown by the fact that many 
neurodegenerative diseases present problems regarding microtubules or the 
proteins that stabilize microtubules [De Vos et al., 2008; Saxena and Caroni, 
2007]. Moreover, one of the early pathogenic mechanisms in neurodegeneration 
seems to be the synaptic dysfunction, meaning that the control of MT scaffold 
in the presynaptic boutons is a fundamental function [Plowey and Chu, 2011].  
 
7.3 DVAP and Sac1 control the vesicular trafficking in the axons of motor 
neurons 
 
We observed that low levels of DVAP and Sac1 selectively in the nervous 
system disrupt vesicular trafficking in the axons of motor neurons. In this 
compartment of the cell the MT structure does not appear to be perturbed, but 
the axonal accumulation of vesicles is reported. Problems regarding axonal 
transport are reported in many human neurodegenerative diseases [De Vos et 
al., 2008]. Some cases of motor neuron diseases are associated to mutations in 
genes encoding proteins involved in vesicle transport on MTs, such as p150
Glued
 
[Dion et al., 2009]. p150
Glued
 forms a complex, called dynactin, interacting with 
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other motor proteins. A model where PI(4,5)P2 molecule together with other 
acidic phospholipids is required to recruit dynein complex to specific organelles 
was proposed in squid [Muresan et al., 2001].  
 
Interestingly, PI(3,5)P2 is involved in the trafficking of endosomal vesicles to 
the tran-Golgi complex. PI(3,5)P2 levels are modulated by Sac3/Fig4 PI5 
phosphtase that has been found mutated in a form of ALS [Chow et al., 2004].  
 
 
7.5 DVAP and Sac1 regulate the organization of the spectrin-actin 
cytoskeleton at the postsynaptic compartment of the Drosophila larval 
NMJ 
 
I observed DVAP and Sac1 also participate together to the correct localization 
of the components of the spectrin-actin cytoskeleton in the postsynaptic 
compartment of the NMJ. Small filaments of actin together with eterotetramers 
of α- and β-spectrin create a reticulum that acts as a framework under the PM 
surrounding the presynaptic boutons [Pielage et al., 2006]. The spectrin-actin 
cytoskeleton seems to contain and support the boutons in the post-synaptic 
compartment [Pielage et al., 2006]. In agreement with this model the 
delocalization of β-spectrin in the post-synaptic compartment that is observed 
when DVAP and Sac1 levels are knocked down in the muscles, is accompanied 
by an alteration of the presynaptic morphology. In particular the synaptic 
membrane presents protrusion similar to spikes. Another protein involved in the 
correct organization of this cytoskeleton has been found mislocalised in muscles 
with low levels of Sac1 and DVAP: the adducin. Adducin acts as an actin-
capping protein and it is required for the recruitment of spectrin to the actin 
filament ends [Hu et al., 2003]. The mislocalization of β-spectrin and adducin 
can indicate that the spectrin-actin cytoskeleton is quite disorganized. 
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Interestingly β-spectrin has a PH domain that mediates the interaction with 
PI(4,5)P2 [Das et al., 2008]. The PH domain is required for spectrin assembly 
[Das et al., 2008], meaning that the binding to PIPs is required for the spectrin-
actin scaffold. Maybe altered PI4P levels can lead to an altered spatial 
distribution of β-spectrin, as PI4P is a precursor of PI(4,5)P2. 
 
Adducin binds PIPs through its myristoylated alanine-rich C-kinase substrate 
(MARCKS) domain, and the interaction of adducin with these lipid molecules 
induces the dissociation of adducin from the actin-spectrin cytoskeleton 
[Barkalow et al., 2003]. Moreover, the actin-capping and the spectrin-recruiting 
activities of adducin are blocked when this protein is phosphorylated by PKC 
[Matsuoka et al., 1998]. High levels of PKC in association with high levels of 
phosphorylated adducin have been reported in ALS sufferers and ALS-SOD1 
murine models [Hu et al., 2003; Shan et al., 2005].  
 
7.6 DVAP-T48I and DVAP-P58S have a dominant negative effect on Sac1 
 
Our data showed that decreased levels of Sac1 cause neurodegeneration, and the 
same was observed for DVAP-T48I and DVAP-P58S [Chen et al., 2008]. These 
results suggest that the interaction between Sac1 and DVAP is kept but Sac1 
function is impaired. Thus, these two mutant alleles of DVAP have a dominant 
negative effect on Sac1. DVAP-T48I and DVAP-P58S cause the formation of 
cytoplasmic aggregates, where these two mutant proteins localize [Chai et al., 
2008; Chen et al., 2010]. The dominant negative effect of these two mutant 
proteins on the wt DVAP is a consequence of the fact that wt DVAP keeps its 
ability to interact with the mutant DVAP, thus, it is trapped into the aggregates. 
wt DVAP cannot fulfil its function because it is mislocalised [Ratnaparkhi et al., 
2008].  
 
I observed that Sac1 is trapped into cytosolic aggregates induced by the 
expression of DVAP-P58S. These data suggests that Sac1 localized into the 
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aggregates cannot function properly, thus, DVAP-P58S has a dominant negative 
effect also on Sac1. The dominant negative effect of DVAP-P58S on wt DVAP 
and Sac1 leads these two proteins to not function properly. Thus, altered 
synaptic morphology, destabilization of MT in the synaptic boutons, altered 
vesicle trafficking in the motor neuron axons, that we observed when DVAP 
and Sac1 are decreased in the nervous system, should resemble the phenotypes 
associated with the expression of DVAP-P58S. The expression of DVAP-T48I 
also induce the formation of aggregates in larval skeletal muscles [Chen et al., 
2010], very likely Sac1 gets trapped in the mutant DVAP-mediated aggregates 
also in skeletal muscles. The mislocalization of Sac1 in skeletal muscles can 
alter the organization of the actin-spectrin scaffold at the post-synaptic 
compartment of the NMJ.  
 
7.7 ALS8 disease is associated altered PI4P metabolism 
 
If Sac1 function is impaired one would expect that PI4P levels are increased as 
Sac1 phosphatase is the only PI4P phosphatase [Blagoveshchenskaya and 
Mayinger, 2009]. Our data support the hypothesis that ALS8 is associated with 
high PI4P levels. Many cellular functions are regulated by different classes of 
PIPs [Di Paolo and De Camilli, 2006]. They include signal transduction and 
stabilization of the actin and MT cytoskeleton. In turn, the regulation of this last 
aspect implicates the regulation of cell migration, phagocytosis, endocytosis, 
cell-cell and cell-matrix adhesion [Di Paolo and De Camilli, 2006]. The 
concentration of all PIP species is finely regulated suggesting the altered 
turnover of one of these lipid molecules very likely can have an impact on the 
majority of the cellular functions just mentioned.  
 
Forrest et al., [2013] showed that PI4P levels are increased when DVAP-P58S 
is expressed as well as when Sac1 levels are decreased. These data suggest that 
the expression of DVAP-P58S is associated with Sac1 impaired function. This 
is in agreement with the dominant negative effect of DVAP-P58S on Sac1. 
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Chapter 8: Future questions and experiments 
8.1 Introduction 
 
The results obtained from the analysis of the interaction between DVAP and 
Sac1, firstly, confirmed that DVAP and Sac1 interact; secondly, it pointed out 
the functional relationship between Sac1 phosphatase activity and DVAP at 
the Drosophila larval NMJ; and lastly, it linked Sac1 to neurodegeneration. In 
addition, the data reported by Forrest et al., [2013] showed the expression of 
DVAP-P58S mutant protein in the nervous system of third instar larvae is 
associated to high levels of PI4P. Moreover, the neurodegenerative phenotype 
observed in the adult eye of Drosophila strains expressing the DVAP-P58S 
mutant protein, is rescued when PI4P levels are brought back to wt levels. All 
together this evidence suggest that PI4P metabolism has a relationship with 
neurodegeneration, but still it is not clear the exact mechanism through which 
the levels of this lipid molecule can induce neurodegeneration. It is possible 
that the neurodegeneration is the consequence of altered pathways at the NMJ. 
In fact, I observed that low levels of Sac1 lead not only to neurodegeneration, 
but also to a number of phenotypes both at the pre- and postsynaptic 
compartments of the larval NMJ. However, it is still undefined the exact 
mechanism through which altered levels of PI4P lipid molecule affect some 
NMJ compartment functions, and they cause neurodegeneration. Therefore, on 
the one hand my data highlighted the involvement of PIPs in ALS8-mediated 
neurodegeneration, on the other hand raised important questions about the 
relationship between PIP metabolism and neurodegenerative diseases, and PIP 





8.2 How MT stability in the motor neurons can be affected by altered 
levels of PI4P? 
 
The evidence reported in this thesis show some cellular mechanisms where 
DVAP and Sac1 proteins cooperate, including MT stability inside the 
presynaptic boutons. In order to investigate whether PI4P levels control either 
directly or indirectly the MT cytoskeleton inside the presynaptic compartment 
few hypothesis have been considered.  
 
The growth cone of motor neurons contains a cytoskeletal structure made of 
MT and actin chains that are in intimate association between each other (fig. 
25)[Lowery and Van Vactor, 2009]. Mutations in yeast Sac1 protein have been 
showed to suppress the phenotypes associated to actin mutations [Novick et 
al., 1989; Cleves et al., 1989]. Therefore, it seems that Sac1 has an effect on 
actin in yeast. The possibility that Sac1 phosphatase activity can be crucial for 
the maintaining of MT structure in the presynaptic boutons of Drosophila 
larvae can be explored looking at the distributions of actin protein in the 




Figure 25. Schematic view of the growth cone of a motor neuron. Dynamic MT filaments 
directly associate with the actin network. Figure from Lowery and Van Vactor,[2009].  
 
8.3 Which is the cause of vesicle accumulation in axons of motor neurons? 
 
I showed in my thesis that when either Sac1 or DVAP levels are alternatively 
lowered into the nervous system, accumulation of important components of 
presynaptic vesicles, is observed into the axons of motor neurons. The cause 
of this accumulation is unclear. Is there a problem in the assembling of 
vesicles at the presynaptic boutons? To address this question it would be 
interesting to look at the distribution of brp and CSP proteins inside the 
presynaptic boutons. Additionally, the accumulation of brp and CSP proteins 
in the axons could be a consequence of the altered MT structure inside the 
presynaptic boutons? To examine this hypothesis the CS larvae can be treated 
with vinblastine. Vinblastine is a microtubule destabilizing drug leading to the 
capping of MT ends [Dhamodharan et al., 1995]. The brp and CSP protein 
accumulation will be checked after the treatment.  
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Can we exclude that a problem in the transport of vesicle is the cause of the 
accumulation of these organelles into the axons of motor neurons? Two genes 
encoding two proteins implicated in axonal transport have been associated to 
ALS: DCTN1 (dynactin-1) and NEFH (neurofilament heavy polypeptide) 
[Munch et al., 2004; Figlewicz et al., 1994]. To address this point the kinetics 
of Brp and CSP can be followed in the axons of motor neurons of larvae 
having low levels of Sac1 in the nervous system. 
 
Lastly it is not clear whether presynaptic vesicles the only organelles that 
accumulate in a knock-down Sac1 or knock-down DVAP context. To address 
this point the markers of organelles that usually are transported through the 
axon to the presynaptic boutons, such as mitochondria, can be checked in the 
axons of motor neurons from Drosophila larvae, where either Sac1 levels are 
decreased.  
 
8.2 Do ALS8 mutations in DVAP affect cellular functions controlled by 
interacting partners others than Sac1? 
 
hVAPB, as well as its Drosophila orthologue, has a number of interacting 
partners besides Sac1, most of them are proteins and enzymes involved in lipid 
transport and metabolism. It would be important to examine the effect of the 
expression of mutations in hVAPB on the functions controlled by its 
interacting partners. The possibility that the phenotypes associated with 
decreased levels of DVAP are only due to the lack of Sac1 stimulation can be 
explored. To this aim, Drosophila melanogaster can be used ones more as 
model organism.  A mutant form of DVAP that is unable to interact with Sac1 
should be overexpressed in loss-of-function background for DVAP. If the OE 
of the mutant form of DVAP, that is unable to interact with Sac1, rescues the 
phenotypes associated to DVAP LOF, the entity of this rescue should be 
quantified and compared to the rescue obtained by DVAP OE. Complete 
rescue of the phenotype should mean that the phenotype caused by decreased 
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levels of DVAP is independent from the activity of Sac1. A partial rescue of 
the phenotype should mean that the phenotype is not only due to the 
inactivation of Sac1. Finally, no rescue should mean that the observed 
phenotype is completely dependent on the interaction between DVAP and 
Sac1.   
 
8.3 Is PIP metabolism altered in cases of the FTDP-17 tauopathy? 
 
High levels of VAPB were found associated with a form of tauopathy called 
FTDP-17. In particular, high levels of VAPB were found in a murine model of 
FTDP-17 [Karsten et al., 2006] and the neurodegeneration in a Drosophila 
model of FTD was reduced by knocking down the function of DVAP. The 
possibility that high levels of VAPB can play a role in the pathogenesis of 
tauopathies affecting PI4P metabolism, can be explored. Thus, the levels of 
PI4P can be analysed in Drosophila strains expressing the mutant form of tau 
in the nervous system. In particular, PI4P can be checked in the larval brains, 
eye imaginal discs, and salivary glands. If the PI4P levels are increased 
compared to control larval nervous system, the possibility that the 
neurodegeneration in the Drosophila model of FTD is affected by altering 
Sac1 phosphatase activity, can be examined. In fact, the PI levels could be 
changed because increased levels of VAPB can have an affect on Sac1 
phosphatase activity.  
 
8.4 Is Sac1 also trapped into DVAP-P58S-associated aggregates in 
muscles? 
 
During my PhD work the localization of Sac1 in the DVAP-P58S-induced 
aggregates was reported in the nervous system. The formation of DVAP 
positive cytosolic aggregates was reported as a consequence of the expression 
in the postsynaptic compartment of another pathogenic mutation of DVAP: 
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T48I [Chen et al., 2010]. The possibility that also the selective expression of 
DVAP-P58S to the muscles causes the formation of aggregates in the 
postsynaptic compartment of the NMJ, and that Sac1 is trapped into these 
aggregates can be explored. This experiment would suggest that the 
phenotypes of the postsynaptic compartment associated with decreased levels 
of Sac1 in that compartment are also present in ALS8 genetic background.   
 
8.5 Does the V234I mutation in hVAPB affect the hVAPB-Sac1 
interaction? 
 
Recently, a third mutation has been identified into hVAPB gene leading to an 
amino acid substitution (V234I) in the TMD of hVAPB protein [van 
Blitterswijk et al., 2012]. Forrest et al.,[2013] shows that the TMD domain of 
the Drosophila orthologue of hVAPB (DVAP) is involved in the interaction 
with Drosophila Sac1 by yeast two-hybrid. As the V234 is a conserved amino 
acid, the possibility that this amino acid between humans and Drosophila, is 
required for the interaction of DVAP with Sac1 can be explored. To this aim 
the Valine in the position 260 of DVAP that corresponds to the Valine234 in 
hVAPB, can be changed into an isoleucine mutagenizing the DVAP cDNA by 
site-directed mutagenesis. The capability of DVAP-V260I to bind Sac1 can be 
examined by yeast two-hybrid assay and, subsequently, can be confirmed by 
Co-IP assay. If the interaction between DVAP and Sac1 is lost as a 
consequence of the V260I mutation, PI4P levels when DVAP-V260I is 
expressed can be checked to investigate whether the phenotypes associated 





8.6 Human genetics analysis of Sac1 gene and of genes encoding enzymes 
implicated in PIP metabolism 
 
If the hypothesis that Sac1 is trapped in hVAPB-P56S positive aggregates, 
ALS8 is associated to a context where Sac1 function is impaired. Thus, it 
would be interesting to analyse ALS patients that resulted negative to mutation 
analysis to the known ALS-associated genes for mutations in Sac1 gene. In 
fact, a mutation that negatively affects Sac1 phosphatase activity can cause the 
same phenotype reported in ALS8 cases. In addition, mutations in enzymes 
directly implicated in lipid metabolism can be searched.  
 
Moreover, Sac1 expression levels can be checked in spinal cords from ALS8-
patient and motor neurons of the Drosophila models of ALS8 in order to 
check whether neurons from spinal cords expressing ALS8-associated hVAPB 
mutant proteins, try to overcome the lack of functional Sac1 in its proper 
subcellular site.  
 
8.7 Is the association between DVAP and its interacting partners, other 
than Sac1, altered in ALS8? 
 
During my PhD work, I focused on the analysis of the interaction between 
DVAP and Sac1, where Sac1 does interact with the TMD of DVAP [Forrest et 
al., 2013]. Some VAP protein interacting partners, including CERT, that bind 
to VAPs through their FFAT motif and VAP’s MSP domain. What does it 
happen to these interactions? How do P56S and T46I mutations affect them? 
The analysis of the interaction between these two mutant forms of DVAP and 
these proteins can be performed. This analysis can reveal whether these 
protein-protein interactions are kept in an ALS8 disease context. 
Consequently, additional cellular functions that are altered in ALS8 NMJ can 
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Although, my PhD study contributed to elucidate the mechanisms underlying 
the neurodegenerative phenotype associated to ALS8, it raised up a number of 
questions. Indeed, Drosophila melanogaster genetics can be used to answer 
the majority of them, but also approaches of cell biology and biochemistry can 
be employed. In conclusion, on the one hand, my study can be considered the 
final step of a short ride, such as the time of a PhD, but on the other hand, the 







Appendix 1. Vector maps  
 
              Figure 26. pCMV-Tag 2 Vector Map from Clontech. 
  
                   Figure 27. pCMV-Myc-N Vector Map from Clontech. 
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               Figure 28. pET-28a Vector Map from Novagen 
 
             Figure 29. pUASTattb Vector Map. Figure adapted from Bischof et al., 2007. 
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